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CHAPTER I 
A Literature Review 
 
Introduction 
Profitability in dairy farms is greatly affected by the reproductive performance of 
the herd (Britt, 1985). Although there are many factors affecting reproductive efficiency 
in dairy cattle, in this dissertation we will focus on postpartum uterine diseases, 
especially endometritis and vaginal purulent discharge. 
During the transition period that corresponds to the three weeks before to three 
weeks after parturition, cows undergo significant changes in feed intake, energy balance 
(Grummer et al., 2004) and metabolic and hormonal profiles (Drackley, 1999). These 
changes predispose postpartum lactating dairy cows to immunodeficiency and to uterine 
diseases (LeBlanc, 2008). 
Uterine bacterial contamination occurs in 80-90% of dairy cows during the first 
two weeks after parturition (Sheldon et al., 2009). On the first weeks after calving, there 
is a cycle of bacterial contamination, clearance and re-contamination of the uterine 
lumen. Most cows are able to solve the uterine bacterial contamination during this period, 
but approximately 10-20% of them will fail in this process and will develop clinical 
endometritis (Potter et al., 2010). Occurrence of uterine infections (i.e. metritis and 
endometritis) is a function of amount and pathogenicity of bacteria to which the uterus is 
exposed to and immune function (Hansen, 2013). 
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Sheldon et al. (2006) classified uterine diseases in the following 5 categories: 
puerperal metritis, metritis, clinical endometritis, subclinical endometritis and pyometra. 
These uterine diseases are highly prevalent in high producing dairy cows (Galvão, 2012) 
and have a negative economic impact on the dairy industry consequent to infertility, 
increased culling for failure to conceive, reduced milk production, and cost of treatment 
(Sheldon et al., 2009). 
Galvão (2012) reported that the risk factors associated with metritis are 
primiparity, dystocia, twin births, retained placenta (RP), stillbirth, abortion, prolapsed 
uterus and ketosis. Similarly, risk factors associated with endometritis are dystocia, twins, 
RP, stillbirth, abortion, metritis, vulva conformation, male offspring, and ketosis. 
Postpartum Microbiota of the Uterus 
The most prevalent bacteria isolated from uterine lumen of cows with uterine 
infection are Escherichia coli and Trueperella pyogenes (Sheldon et al., 2009). 
Escherichia coli is a gram negative bacteria that resides in cow’s digestive tract as part of 
the normal flora. After parturition, the presence of lochia in the uterus combined with 
intrauterine temperature and pH, create a favorable environment for bacterial 
multiplication (Hussain et al., 1990). Escherichia coli is one of the most prevalent 
bacteria isolated in the first days after calving (Hussain et al., 1990) and is reported to 
precede infection with T. pyogenes, which is isolated from cows with severe clinical 
endometritis (Williams et al., 2007). 
Trueperella pyogenes expresses several virulence factors that result in severe 
endometrial lesions. Pyolysin (PLO), a potent extracellular toxin, is a primary virulence 
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factor produced by T. pyogenes. Pyolysin, is a haemolysin because it has the capacity of 
lysing red blood cells. Moreover, PLO is cytolytic to several cell types including 
polymorphonuclear leukocytes (PMNL) and macrophages. The mechanism for the PLO 
cytolytic effect is through formation of large pores in eukaryotic cell membranes, leading 
to osmotic death (Jost and Billington, 2005).       
Fusobacterium necrophorum and Prevotella species are anaerobes that act 
synergistically with T. pyogenes increasing likelihood and severity of uterine disease 
(Sheldon et al., 2009). Bonnett et al. (1991) reported that the presence of T. pyogenes in 
biopsies collected at 26 days postpartum (DIM) was positively correlated with isolation 
of anaerobic bacteria (e.g. Clostridium, Fusobacterium, Peptococcus, 
Peptostreptococcus) and presence of segmented inflammatory cells on the same biopsy. 
Moreover, authors demonstrated a strong association between isolation of T. pyogenes 
and anaerobic bacteria 26 DIM and increased histological abnormalities in uterine 
biopsies collected 40 DIM.   
Williams et al. (2005) categorized bacterial isolates form 328 swabs collected 
from uterine lumen of dairy cows 21 and 28 DIM in three categories according to their 
expected pathogenic potential. The first category comprises recognized uterine pathogens 
associated with uterine endometrial lesions and included: T. pyogenes, P. 
melaninogenicus, E. coli and F. necrophorum. The second category is formed by 
potential pathogens frequently isolated from the bovine uterine lumen and cases of 
endometritis not commonly associated with uterine lesions: Bacillus licheniformis, 
Enterococcus faecalis, M. haemolytica, Pasteurella multocida, Peptostreptococcus 
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species, Staphylococcus aureus and non-haemolytic Streptococci. The third category is 
formed by opportunistic contaminants transiently isolated from the uterine lumen and not 
associated with endometritis: Clostridium perfringens, Klebsiella pneumonia, 
Micrococcus species, Providencia stuartii, Proteus species, Staphylococcus species 
(coagulase negative), α-haemoltyic Streptococci, Streptococcus acidominimus, and 
Aspergillus species. Bovine herpervirus 4 is the only virus consistently associated with 
uterine diseases in postpartum cows and its presence is normally concurrent with bacteria 
that are known to cause uterine disease (Sheldon et al., 2009).  
Endometritis Diagnosis 
Clinical endometritis is characterized in cattle as the presence of a purulent (> 
50% pus) uterine discharge detectable in the vagina after 21 DIM or a mucopurulent 
discharge (approximately 50% pus and 50% mucus) detectable in the vagina after 26 
DIM without any systemic symptoms (Sheldon et al., 2006).   
The diagnosis of clinical endometritis can be made simply by visualization of 
fresh and characteristic discharge from the vulva or on the perineum and tail (LeBlanc et 
al., 2002). If discharge is not visible externally, which is often the case, the diagnosis can 
be made through an evaluation of the vaginal discharge using vaginoscopy (LeBlanc et 
al., 2002), the gloved hand (Sheldon et al., 2002), or the Metricheck device (McDougall 
et al., 2007). When performing any of these three methods, the vulva needs to be well 
cleansed in order to avoid introduction of contaminants into the vagina (Galvão, 2012) 
and the instruments used must be clean and lubricated. 
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For the vaginoscopic examination, the vaginoscope is inserted into the vagina 
until it touches the external os of the cervix (the opening of the lower part of the cervix 
that protrudes into the vagina). Cervix and vagina are then visually examined with 
illumination from a penlight for presence and quality of the discharge (LeBlanc et al., 
2002). 
In the gloved hand method, vaginal discharge is scooped by hand. A gloved hand 
is inserted through the vulva, and the lateral, dorsal and ventral walls of the vagina and 
the external cervical os are palpated. Vaginal discharge is then withdrawn for 
examination (Sheldon et al., 2002). 
A fairly new device called Metricheck has also been used to diagnose 
endometritis in cattle. This device was invented in New Zealand (Simcro, New Zealand) 
but has become popular around the world because it is easier and faster than 
vaginoscopy. The metricheck device consists of a stainless steel rod with a semi-spherical 
rubber cup that is used to retrieve vaginal contents. To examine a cow, the device is 
introduced through the vulva into the cranial vagina to scoop any vaginal discharge from 
the anterior vagina (Runciman et al., 2009). 
The efficacy of vaginoscopy and metricheck to diagnose clinical endometritis 
were compared (McDougall et al., 2007; Runciman et al., 2009). McDougall et al. (2007) 
examined 191 cows with more than 14 DIM and history of periparturient disease for 
clinical endometritis using both the metricheck and the vaginoscope. The order of 
examination (metricheck first vs. vaginoscope first) was randomized within each herd. 
Three analytical approaches were used to estimate test sensitivity and specificity for 
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detection of endometritis in absence of a gold standard. In all three approaches, the 
metricheck had a higher sensitivity but lower specificity than vaginoscopy. Using the 
maximum likelihood approach, for instance, sensitivity was 96.2% vs. 71.5% and 
specificity was 77.6% vs. 87.1% for metricheck and vaginoscopy, respectively.  
Runciman et al. (2009) examined 423 postpartum dairy cows with both 
metricheck and vaginoscopy between 7 and 28 DIM. Vaginally retrieved exudate was 
scored from 0 (clear or absent) to 3 (purulent). Vaginal exudate score from individual 
cows obtained with Metricheck and vaginoscopy were compared using a quadratic 
weighted kappa and agreement between the two methods was substantial [kappa = 0.73 
(95% CI 0.66–0.80)] when assessing the status (pus or no pus) of the discharge. Authors 
suggested that the diagnosis of purulent exudate in the vagina of dairy cows using the 
Metricheck might be better than using vaginoscope because the Metricheck is quicker 
and easier than vaginoscopy and  there is no difference in sensitivity for detection of 
purulent or mucopurulent vaginal discharge between the two techniques. 
Pleticha et al. (2009) evaluated the incidence of endometritis in 2 German dairy 
herds based on the metricheck, gloved hand, and vaginoscopy. Cows (n = 1,002) were 
examined for clinical endometritis 21 to 27 DIM using one of the three methods and 
those diagnosed with endometritis were treated with an analogue of prostaglandin (PG) 
F2α twice, 14 d apart. Incidence of clinical endometritis was significantly greater in cows 
examined with Metricheck (47.5%) compared with cows examined with vaginoscopy 
(36.9%) and gloved hand (36.8%). There were no differences in reproductive 
performances of cows according to diagnostic method. Authors suggested that the lack of 
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differences among diagnostic methods in regards to reproductive performance may have 
been a consequence of low specificity of the Metricheck method or inefficiency of PGF2α 
in resolving endometritis. 
The definitive diagnosis of endometritis is made through histological examination 
of endometrial biopsies (Sheldon et al., 2006). According to Bondurant (1999), 
endometritis is histologically characterized by disruption of surface epithelium, 
inflammatory cells infiltration, vascular congestion, stromal edema, and by varying 
degrees of lymphocyte T and B cells accumulation in the superficial layers. The 
downsides of this procedure is that it is costly, time consuming, may depress fertility 
(Sheldon et al., 2006), and well trained personnel are required. Bonnett et al. (1991) 
described the procedure for endometrial biopsies and histological assessment. Briefly, 
biopsy of endometrium may be performed using a 3/8 inch diameter biopsy punch (Equi 
Bov, Campbellville, Ontario). Biopsies are taken from the dorsomedial region of the 
horn, just anterior to the bifurcation, from the larger horn that is presumed to be the 
previously gravid horn. Biopsies are then gently removed from the biopsy instrument and 
transferred to a vial of Bouin’s solution. After two to four hours, the samples are 
transferred to 70% alcohol. After that, sections are cut and processed routinely and 
stained with hematoxylin and eosin. 
Ultrasonography and rectal palpation are also useful tools for examining cows for 
endometritis. In a study conducted by LeBlanc et al. (2002), cows with cervical diameter 
> 7.5 cm after 20 DIM had impaired reproductive performance and were considered to 
have had clinical endometritis. Mateus et al. (2002) evaluated the use of ultrasonography 
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to measure uterine body diameter, intrauterine fluid volume (scored from 0 = no fluid; 1-
3 = increasing spots of fluid) and ovarian function of 26 dairy cows from parturition to 
the sixth week postpartum. Cows were allocated to one of three categories according to 
uterine lochia: healthy group (normal lochia, n = 7), mild endometritis (purulent lochia, n 
= 11), and severe endometritis (heavy, fetid and purulent lochia with or without systemic 
symptoms, n = 8). Cows with severe endometritis had significantly larger uterine body 
diameter than the other categories 3 and 4 weeks postpartum. Cows with severe 
endometritis had significantly larger intrauterine fluid volume than healthy and mildly 
endometritic cows 2, 5 and 6 weeks postpartum. In addition, cows with mild endometritis 
had numerically higher score for intrauterine fluid volume from 0 to 5 weeks postpartum, 
but the difference was significant only in week 3. Cows with severe endometritis were 
more likely to have prolonged anoestrus, prolonged luteal phases and ovarian cysts than 
healthy cows.  
Subclinical endometritis 
Subclinical endometritis is an inflammation of the endometrium without presence 
of purulent discharge in the vagina. The diagnoses of subclinical endometritis can be 
done by measuring the proportion of neutrophils present in uterine cytology samples 
collected using the cytobrush (Kasimanickam et al., 2004) or the low-volume uterine 
lavage procedure (Gilbert et al., 2005). 
In the uterine cytology technique, a cytobrush (VWR Canlab, Mississauga, ON, 
Canada) designed for humans is used (Kasimanickam et al., 2004). In order to use a 
human cytobrush in cows, the plastic handle of the cytobrush is cut to 3 cm in length, 
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threaded onto a solid stainless steel rod (65 cm in length and 4 mm in diameter), and 
placed in a stainless steel tube (50 cm in length and 5 mm in diameter). The stainless steel 
instrument is protected with a sanitary plastic sleeve to avoid contamination of the 
cytobrush with vaginal content. After cleaning the vulva, the lubricated instrument is 
inserted into the vagina and directed to the external cervical os, the sanitary sleeve is 
punctured, and the instrument advanced through the cervix into the base of the larger 
horn, presumably the previously gravid horn. The cytobrush is then exposed and uterine 
sample is collected by rotating the cytobrush in a clockwise direction while in contact 
with the uterine wall. The cytobrush is then retracted into the stainless steel tube, the 
instrument is removed, and the slide is prepared by rotating the cytobrush in a glass 
microscope slide. Subclinical endometritis can also be diagnosed using the low-volume 
uterine lavage procedure. In this technique, 20 mL of sterile saline solution is infused into 
the uterus using a sterile infusion pipette protected by a sanitary sleeve. The infusion 
pipette is introduced through the vulva and directed to the cervix, and the sanitary sleeve 
is punctured while the infusion pipette is inside the cervix, and then the pipette is placed 
into the uterine body. Upon infusion, the uterus needs to be massaged, and at least 5 mL 
of the infused fluid is aspirated. Aspirated fluid must be processed within 6 hours. 
Samples need to be centrifuged using either a conventional or cytospin centrifuge. When 
using a conventional centrifuge, most of the supernatant is discarded and just one 
remaining drop is used to prepare the smear on a microscope glass slide. If using a 
cytospin centrifuge, approximately 150 µl of aspirated fluid is transferred to a cytospin 
container and samples are centrifuged onto glass slides at 700 g for 5 min. Slides are air-
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dried, stained using Diff-Quik, and read under 400x magnification. Endometrial 
inflammation is determined based on the percentage of PMNL in the smear after counting 
a minimum of 100 cells, excluding erythrocytes (Gilbert et al., 2005; Galvão, 2012). 
Kasimanickam et al. (2004) evaluated the cytobrush technique and 
ultrasonography to diagnose subclinical endometritis in postpartum dairy cows. Holstein 
cows were examined for vaginal discharge using a vaginoscope between 20 and 33 DIM 
and 228 clinically normal cows were enrolled in the experiment. These clinically normal 
cows were further examined by ultrasonography and endometrial cytology 20-33 DIM 
and 14 days later and their reproductive performance was evaluated for a minimum of 8 
months or until diagnosed pregnant or culled. Cows with > 18% PMNL in uterine 
cytology 20-33 DIM [AHR (95% CI) = 0.59 (0.43, 0.81)] and cows with > 10% PMNL 
in uterine cytology 34-47 DIM [AHR (95% CI) = 0.56 (0.41, 0.78)] had reduced adjusted 
pregnancy hazard ratio than cows with < 18% PMNL in uterine cytology 20-33 DIM and 
cows with < 10% PMNL in uterine cytology 34-47 DIM. In regards to the 
ultrasonography examination, cows that had intrauterine fluid at 20-33 DIM [AHR (95% 
CI) = 0.46 (0.33, 0.74)] and at 34-47 DIM [AHR (95% CI) = 0.58 (0.36, 0.94)] had 
reduced adjusted pregnancy hazard ratio than cows with no intrauterine fluid in each 
examination.  Therefore, presence of fluid or > 18% PMNL in uterine cytology 20-33 
DIM and presence of fluid or > 10% PMNL in uterine cytology 34-47 DIM are 
associated with compromised reproductive performance. 
In a subsequent experiment the cytobrush and the uterine lavage techniques were 
compared for diagnosis of sub-clinical endometritis (Kasimanickam et al., 2005). 
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Holstein cows (n = 35) that did not have abnormal vaginal discharge based on 
vaginoscopy 20 to 33 DIM were used in the study. Endometrial samples were collected 
from all cows by the cytobrush technique followed by the lavage technique between 20 
and 33 DIM and between 34 and 47 DIM.  The cytobrush technique resulted in 
significantly higher percentage of PMNL in uterine cytology than the lavage technique 
between 20 and 33 DIM but no differences were observed between the cytobrush and 
lavage techniques between 34 and 47 DIM. There was a negative correlation between 
uterine diameter and fluid recovery by the lavage technique. Therefore, authors 
speculated that the observed differences between cytobrush and lavage techniques 
between 20 and 33 DIM were because of the larger uterine volume and reduced cell 
recovery. Authors concluded that cytobrush technique is a more consistent and reliable 
method than the uterine lavage to obtain endometrial cytology samples from postpartum 
dairy cows.            
Ghasemi et al. (2012) suggested that endometrial inflammation can be predicted 
by measuring cytokine gene expression in endometrial cytobrush samples. In this 
experiment, cows were examined for subclinical endometritis at 28-41 DIM using the 
uterine cytology technique, and cows with > 18% of PMNL in uterine cytology were 
considered to have sub-clinical endometritis. Cytobrush from cows with subclinical 
endometritis contained a 20-fold higher tumor necrosis factor alpha (TNFα), a 30-fold 
higher interleukin (IL) 6, and a greater than 50-fold higher IL-8 mRNA expression than 
cytobrush from healthy cows. Even though the authors suggested that IL-8 gene 
expression in cytobrush might be a useful tool to predict endometrial inflammation in 
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cattle, sample size in this experiment was not sufficient to calculate sensitivity and 
specificity. 
Endometritis Treatment 
There are no commercial products currently approved for treatment of 
endometritis in dairy cows in the United States. However, intrauterine treatment of 
endometritic cows using 500 mg of cephapirin benzathine in 19 g ointment base 
(Metricure®, Intervet, Boxmeer, The Netherlands) is approved in Canada, Europe and 
New Zealand (Galvão, 2012). LeBlanc et al. (2002) compared the reproductive 
performances of endometritic cows treated, at 20 and 33 DIM, with Metricure®, or 
intramuscular (i.m.) injection of 500 μg of cloprostenol, or not treated. Intrauterine 
treatment of endometritic cows with Metricure® improved pregnancy rates by 63% 
compared with untreated cows but only when cows were treated between 27 and 33 DIM. 
There were no differences in reproductive performance between PGF2α treated 
endometritic cows and untreated endometritic cows. Kasimanickam et al. (2005) 
demonstrated improvements in reproductive performance of cows with subclinical 
endometritis treated with Metricure® and cloprostenol at 20 to 33 DIM. On the other 
hand, Dubuc et al. (2011) demonstrated that treatment of cows with clinical and 
subclinical endometritis with PGF2α at both 35 and 49 DIM did not improve reproductive 
performance. Similarly, Lima et al. (2013) observed no benefit of a single PGF2α 
treatment at 36 to 42 DIM, or 2 treatments with PGF2α at 22-28 DIM and 36-42 DIM  in 
uterine health or reproductive performance. Treatment of endometritic cows with PGF2α 
has been suggested to improve uterine health by inducing estrus in cows with a corpus 
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luteum, resulting in physical expulsion of bacteria, increased concentrations of pro-
inflammatory substances in the uterus (i.e. PGF2α and estradiol), and reduced 
progesterone concentrations eliminating the immunosuppressive effects of progesterone 
in the uterus (Galvão, 2012). Progesterone is believed to cause immunosuppression in 
part due to the down-regulation of expression of molecules associated with bacterial 
recognition (i.e. tool-like receptor (TLR) 4), reduced expression of mRNA of pro-
inflammatory genes (CXCL5, IL-1β, and IL-8; Fischer et al., 2010), and inhibition of 
endometrial stroma and epithelial cells’ production of PGE and PGF in response to 
lipopolysaccharides (LPS; Herath et al., 2006). Up to date, however, the only treatment 
that appears to effectively improve fertility of endometritic cows is the intra-uterine 
treatment with Metricure®. 
Effects of Uterine Diseases on Ovarian Function 
The presence of postpartum uterine infection is associated with impaired ovarian 
function (Sheldon et al., 2002; Sheldon et al., 2009; Williams et al., 2007; Williams et al., 
2008). The negative effect of uterine microbes on ovarian function is a complex 
mechanism involving the innate immune system and inflammatory mediators that are 
believed to interact with the hypothalamus, pituitary and ovary (Sheldon et al., 2009). 
Beginning during parturition, cows have the uterus contaminated by a variety of 
bacteria, both gram-positive and gram-negative aerobes and anaerobes (Azawi, 2008). 
The outer membrane of cell walls of gram-negative bacteria is formed by proteins, 
phospholipids, and by its major component, LPS (Beveridge, 1999). Lipopolysaccharides 
suppress hypothalamic release of gonadotropin-releasing hormone (GnRH), reduce the 
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sensitivity of the pituitary to GnRH, and reduce the secretion of luteinizing hormone by 
the pituitary (Sheldon et al., 2009). Interestingly, follicle-stimulating hormone 
concentration is not affected by uterine bacterial contamination, and therefore the 
emergence of ovarian follicular waves is not compromised in animals with uterine 
disease (Sheldon et al., 2002). 
Lipopolysaccharides also have a direct negative effect in the ovarian function. 
Williams et al. (2008), using cells collected from bovine ovaries, reported reduced 
granulosa cell estradiol secretion when cells were treated with LPS. Also, treatment of 
theca and granulosa cells with TNFα, an important pro-inflammatory cytokine produced 
after LPS stimulation, resulted in decreased theca cell production of androstenedione and 
granulosa cell production of estradiol. Intrauterine infusion of Holstein heifers with 3 
µg/kg of LPS or 0.1 µg of rhTNFα resulted in fewer ovulations than heifers treated with 
sterile phosphate-buffered saline and, among heifers that ovulated, progesterone 
concentration was lower in heifers treated with LPS. Furthermore, cows with elevated 
uterine bacterial contamination 7 DIM had smaller dominant follicles and reduced 
estradiol concentration during the first postpartum follicular wave and smaller corpora 
lutea and progesterone concentration after ovulation (Williams et al., 2007). Luteal phase 
may also be disrupted and shortened in cows with endometritis. Endometrial cells 
challenged with LPS had greater secretion of PG, with a greater PGE to PGF ratio 
(Herath et al., 2006; Sheldon et al., 2009). During the normal estrus cycle luteolysis is 
caused by secretion in pulses of PGF2α by the endometrium at approximately day 17 of 
the estrus cycle in non-pregnant cows (Miyamoto and Shirasuna, 2009). On the other 
 15 
 
hand, PGE is luteotropic (Manns et al., 1985; Davidson et al., 1996) and intrauterine 
infusion of heifers with PGE2 resulted in extended luteal phase (Thibodeaux et al., 1992). 
Therefore, endometritis may predispose cows to pyometra because the increased PGE to 
PGF ratio associated with endometritis would prolong the maintenance of the corpus 
luteum, an ideal condition for maintenance and worsening of uterine bacterial infections. 
Lipopolysaccharide Recognition by the Innate Immune System 
Innate immunity is the first line of host defense against infections, and plays an 
important role in pathogen recognition and triggering the subsequent inflammatory 
response. Cells from the innate immune system are capable of recognizing host self and 
nonself molecules through receptors called pattern recognition receptors (PRR; 
Mogensen, 2009). These receptors recognize molecular structures that are conserved 
through several classes of microbes, called pathogen-associated molecular patterns 
(PAMP). Pathogen-associated molecular patterns are essential for the survival of the 
microbe and, therefore, are not subject to variability, as changes in these structures are 
lethal to the microbe (Medzhitov and Janeway, 1997). 
One of the most studied PAMP is the LPS, constituent of the outer membrane of 
gram-negative bacteria cell wall. The LPS molecule is composed of three structural 
sections: an amphipathic Lipid A, a hydrophilic polysaccharide of the core, and O-
specific chain (Figure 1). The Lipid A component is responsible for the endotoxic 
principle of LPS. Chemically, Lipid A consists of phosphorylated glucosamine 
disaccharide units with long-chain fatty-acids attached. The core polysaccharide is 
formed by two characteristic sugars [ketodeoxyoctanoic acid (KDO) and a heptose] and 
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connects the Lipid A and O-specific chain sections. The core region can be subdivided 
into an outer and an inner portion, where the inner core is well conserved among all 
gram-negative bacteria, being essential for LPS structure and bacterial viability. The third 
section, O-specific chain, is formed by a polymer of oligosaccharides with repeating units 
of glycosyl residues (Rietschel et al., 1994). The O-specific chain is the most chemically 
diverse component of the LPS outer membrane, varying among even the same species of 
bacteria (Kalynych et al., 2012) and, therefore, functioning as an important surface 
antigen, also referred to as the O-antigen. 
In mammals, the physiological recognition of bacterial LPS occurs through the 
TLR-4 in association with myeloid differentiation factor 2 (MD-2; Park et al., 2009). 
Members of TLR family are composed by three different domains (Figure 2): an 
extracellular domain composed of many leucine-rich repeat (LRR), a membrane-
spanning domain, and an intracellular domain, termed toll-interleukin-1 receptor (TIR) 
domain (Medzhitov, 2001). 
Lipopolysaccharide while within bacterial membranes cannot effectively induce 
an immune response. To actively stimulate the immune system, LPS needs to be 
extracted from the bacterial membrane and be presented to the receptor complex 
composed of TLR4 and MD-2. For that, a serum lipid transfer protein called LPS-binding 
protein extracts monomers of LPS from the bacterial membrane and presents them to the 
innate immune receptor cluster of differentiation (CD) 14, expressed on myelomonocytic 
cells or soluble in the circulation. The role of the CD14 is to load the LPS to the receptor 
complex formed by TLR4 and MD-2 (Miyake, 2006). 
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Tool-like receptor 4 TIR domain is critical for signal transduction after LPS 
binding to the complex TLR4-MD-2. Toll-interleukin-1 receptor domains are composed 
of three highly conserved regions that play an important role in the protein-protein 
interactions among TLR4 and five adaptor proteins, leading to the activation of 
transcription factors such as nuclear factor-κB (NF-κB) and members of the interferon 
(IFN)-regulatory factor family (Lu et al., 2008; O’Neill and Bowie, 2007). The activation 
of these two factors regulates the transcription of a variety of genes, including cytokines 
and chemokines, being crucial for controlling the innate and adaptive immunity (Li and 
Verma, 2002; Schroder et al., 2004). 
Lipopolysaccharides stimulate the production of pro-inflammatory cytokines, 
such as TNFα, IL-1, IL-6 and IL-8 (Wright, 1999), which are produced by many different 
cell types. Interleukin-1 and TNFα are functionally related pro-inflammatory cytokines 
that mediate many of the consequences of sepsis, including fever, induction of acute-
phase proteins, migration of inflammatory cells, vasodilatation and stimulation of other 
cytokines (Marsh et al., 1994). Interleukin-6 is a cytokine with both pro and anti-
inflammatory properties, and might play an important role during the transition of innate 
to acquired immunity. Interleukin-6, in association with IL-1β or TNFα, stimulates the 
production of various chemokines leading to the attraction of neutrophils in the initial 
phase of inflammation. However, 24-48 h after initial infiltration, neutrophils are 
replaced by monocytes and T cells in order to prevent tissue damage from accumulation 
of proteases and reactive oxygen species produced by neutrophils. Within this context, 
IL-6 induces neutrophil apoptosis contributing to resolution of the acute neutrophil 
 18 
 
infiltration (Scheller et al., 2011). Interleukin-6 also upregulates expression of adhesion 
molecules on endothelial cells and leukocytes, favoring the process of leukocyte 
transmigration from blood circulation to inflamed tissues (Scheller et al., 2011). In 
addition to regulating the immune response, IL-6 also plays an important role in acute 
phase reaction and hematopoiesis (Tilg et al., 1995). Interleukin-6 acts as a hepatocyte-
stimulating factor inducing production of various acute-phase proteins in the liver. 
Moreover, IL-6 also acts on hematopoietic stem cells and, together with IL-3, promotes 
the transition from a resting phase to a proliferative phase of the cell cycle. In addition, 
IL-6 induces maturation of megakaryocytes, resulting in an increase in platelets 
(Kishimot et al., 1992). Interleukin-8 is a cytokine produced by variety of cell types and 
is a member of the chemokine family, acting to guide leukocytes, primarily neutrophils, 
to the site of inflammation. Interleukin-8 also stimulates neutrophil function by 
increasing the ability of neutrophils to adhere to stimulated endothelial cells, increases 
neutrophil expression of integrin adhesion molecules LFA-1 (CD11aCD18) and MAC1 
(CD11bCD18), and induces neutrophils to release lysosomal enzymes (Harada et al., 
1994). 
Leukocytes Migration 
Leukocyte activation and migration to the site of inflammation is a crucial 
component of both innate and adaptive immunity. In order to transmigrate from the blood 
vessel into inflamed tissues, leukocytes need to interact with the endothelium (Albelda et 
al., 1994). Four families of cell adhesion molecules (CAM) play a critical role in 
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leukocytes endothelial interactions: the selectin family, the mucin-like family, the 
integrin family, and the immunoglobulin superfamily (Kindt et al., 2006). 
The selectin family is responsible for the initial stickiness of leukocytes to 
endothelium, allowing leukocytes to roll along vascular endothelium (Kindt et al., 2006). 
This family includes three molecules designated by the prefixes L (leukocyte), P 
(platelet), and E (endothelial; Carlos and Harlan, 1994). L-selectin is expressed by 
hematopoietic cells, with most classes of leukocytes expressing L-selectin at some stage 
of differentiation (Tedder et al., 1995). P-selectin is expressed in the α-granules of 
platelets and in the Weibel-Palade bodies of endothelial cells (André, 2004). E-selectin, 
similarly to P-selectin, is expressed by endothelial cells. Thus, P-selectin and E-selectin 
are upregulated on endothelium surface upon an inflammatory stimulus (Binder and 
Ernst, 2011). 
Mucins are a group of proteins with extended structure that serve as binding site 
for selectins. L-selectin expressed by leukocytes, for example, binds to the mucin-like 
molecules CD34 and GlyCAM-1 of endothelial cells. Neutrophils express a mucin-like 
molecule (PSGL-1) that binds to E-selectin and P-selectin expressed on endothelium 
(Kindt et al., 2006). 
Members of the integrin family while interacting with members of 
immunoglobulin superfamily, play an important role in leukocytes firm adhesion and 
diapedeses during leukocyte emigration from the bloodstream to extravascular tissues 
(Carlos and Harlan, 1994). The integrin family is composed by heterodimer proteins 
consisting of noncovalently associated α and β subunits (Albelda and Buck, 1990). One 
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of the most important functions of integrins is to bind to extracellular matrix molecules 
and provide cell matrix interactions throughout the body (Aplin et al., 1998). Leukocytes 
express a subfamily of integrins called β2-integrins (CD18) that can be associated with 
three distinct α subunits (CD11a, CD11b, and CD11c; Mazzone and Ricevuti, 1995). The 
combination of integrins expressed by a cell type will permit these cells to bind to 
different CAMs expressed on vascular endothelium (Kindt et al., 2006). 
The fourth family of CAMs is called immunoglobulin superfamily and is 
composed of more than 765 members, being one of the largest and most diverse proteins 
in the body. In this group are included the major histocompatibility complex classes I and 
II, cell surface glycoproteins, virus receptor and proteins of the T-cell receptor complex 
(Wai Wong et al., 2012). Cell surface glycoproteins include ICAM-1 (CD54), ICAM-2 
(CD102), ICAM-3 (CD50), and VCAM (CD106), which are expressed on vascular 
endothelial cells and bind to several members of the integrins family (Kindt et al., 2006). 
Polymorphonuclear Leukocytes Phagocytosis and Oxidative Burst 
Polymorphonuclear leukocytes, especially neutrophils, are the predominant 
migratory phagocytic cells present in blood and are the first cells to arrive at sites of 
infection. Therefore, PMNL are crucial for host defense against bacterial infections 
(Chang et al., 1999) and non-specific phagocytosis by neutrophils is one of the most 
important lines of defense against establishment of uterine infections (LeBlanc, 2008). 
By definition, phagocytosis is the process of engulfing particles such as pathogens 
into a plasma membrane-derived vacuole, termed phagosome, which proceeds to acquire 
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degradative properties through action of cytotoxic agents in a process called maturation 
(Lee et al., 2003). 
Phagocytic processes are driven by controlled rearrangement of the actin 
cytoskeleton (May and Machesky, 2001), which allows neutrophils to internalize both 
opsonized and non-opsonized particles. Opsonization enhances phagocytosis and the two 
principal opsonin receptors of neutrophils are Fc receptors and the β2 integrin MAC1 
(Lee et al., 2003). 
Fc receptors bind to Fc portion of immunoglobulin and, for PMNL, the expression 
of Fc receptors depends on the stage of cellular activation. In humans, the main Fc 
receptors are FcγRI, FcγRIIA, and FcγRIIIb. Resting PMNL express FcγR IIA and IIIb, 
whereas FcγRI receptors are expressed by neutrophil undergoing development and upon 
stimulation of neutrophils by IFN-γ and granulocyte colony-stimulating factor 
(McKenzie and Schreiber, 1998). Neutrophil β2 integrin MAC1 (CD11bCD18) 
recognizes complement-coated particles by recognizing the complement fragment C3bi 
(Lee et al., 2003). 
Upon phagosome formation, the phagosome moves toward the interior of the cell 
and fuses with a lysosome, forming a phagolysosome, in which the killing and digestion 
of the bacteria takes place. Lysosomes are cellular organelles that contain a variety of 
hydrolytic enzymes that digest the ingested material (Kindt et al., 2006). 
The production of reactive oxygen species, during the process called oxidative 
burst, plays a critical role in bacteria killing. Large amounts of superoxide are generated 
by a NADPH oxidase, a multisubunit entity with membrane-bound and soluble 
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components that assemble into a heteromeric complex when the cells are stimulated (Lee 
et al., 2003). Activation of NADPH oxidase can be induced by LPS, by lipoproteins, or 
by cytokines such as IFN-γ, IL-1β, and IL-8 (Droge, 2002). Neutrophils express several 
TLR on their surface, including TLR2 that detects the peptidoglycan of gram-negative 
bacteria, and TLR4 that recognizes LPS (Kindt et al., 2006). NADPH oxidase activation 
can be in response to signaling events involving TLR and FcγR (Huang et al., 2009). 
Myeloperoxidase (MPO) is an enzyme, cationic protein, stored in large amounts 
in azurophilic granules of PMNL. Within the azurophilic granules, which have low pH 
and lack hydrogen peroxide, MPO bound to proteoglycans, mainly chondroitin-4-
sulphate, are inactive. Upon bacteria phagocytosis, however, azurophilic granules 
discharge their content into the forming phagosome. With NADPH oxidase activation 
and ion influx into the phagosome, local conditions are changed, favoring the activation 
of MPO and other compounds present in the azurophilic granules (Arnhold and Flemmig, 
2010). The combined activities of MPO and NADPH oxidase lead to the production of 
hypochlorous acid (HCLO), a potent antibacterial substance (Droge, 2002). 
Myeloperoxidase also regulates inflammation by promoting recruitment of PMNL and 
apoptosis of PMNL and other cells (Arnhold and Flemmig, 2010).   
Endometrium and Innate Immunity  
Endometrium is the physical barrier against establishment of uterine diseases. 
Endometrium possesses TLR (1 to 10) for pathogen recognition and produces 
antimicrobial peptides and Mucin-1 (Davies et al., 2008). 
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Antimicrobial peptides in mammals are divided in two main genetic categories, 
the cathelicidins and the defensins. Defensins in vertebrates are subdivided in three 
subfamilies (α, β, and θ; Selsted and Ouellette, 2005), of which β-defensins is the main 
sub-family and is of particular importance for mucosal immunity (Davies et al., 2008). 
Microbicidal effects of defensins have been demonstrated by in vitro studies, in which 
purified defensins preparations killed a wide range of microbes, including bacteria, fungi, 
protozoa and enveloped virus (Selsted and Ouellette, 2005). 
Mucin 1 is an epithelial cell glycosylated transmembrane protein expressed in 
bovine endometrium that might play an important role in microbial defense by limiting 
microbial access to the cell surface, regulating inflammation. Interestingly, treatment of 
endometrial cells with LPS resulted in upregulation of expression of MUC-1 (Davies et 
al., 2008). 
The inflammatory process that results from the contact between the endometrium 
and pathogens is critical for elimination of the pathogen or infection. It is well 
documented that cows with uterine diseases have increased endometrium gene expression 
of pro-inflammatory cytokines. Fischer et al. (2010) found that cows with subclinical or 
clinical endometritis had increased expression of CXCL5, IL-1β, IL-8 and TNFα at 21-27 
DIM compared with healthy animals. 
Galvão et al. (2011) evaluated endometrium mRNA gene expression of pro-
inflammatory (TNFα, IL-1β, IL-6 and IL-8) and anti-inflammatory (IL-10) cytokines in 
cows that developed endometritis and in healthy cows at weeks 1, 3, 5 and 7 after 
calving. Expression of mRNA gene for TNFα and IL-1β were reduced in week 1 after 
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calving in cows diagnosed with endometritis 5 weeks after calving compared with 
healthy cows. Expression of mRNA of genes for pro-inflammatory cytokines (IL-1β, IL-
6 and IL-8) was increased in endometritic cows on weeks 5 and/or 7 after calving 
compared with healthy cows. There was no difference in expression of mRNA gene for 
IL-10 between health and endometritic cows. Tumor necrosis factor alpha and IL-1β are 
known to stimulate IL-8 production and expression of adhesion molecules on vascular 
endothelium. Therefore, TNFα and IL-1β are critical for leukocytes chemoattraction, 
migration and activation. The authors  (Galvão et al., 2011) suggested that the decrease in 
expression of TNFα and IL-1β 1 week after calving in cows diagnosed with endometritis 
5 weeks after calving compared with healthy cows may have compromised bacterial 
clearance after calving and contributed to occurrence of endometritis.  
The endometrium also mediates inflammation through the production of 
prostaglandins. For example, LPS challenge of endometrial epithelial and stromal cells 
results in increased PG secretion, with an increased ratio of PGE to PGF (Herath et al., 
2006). Prostaglandins of the E series modulate inflammation and immune responses and 
are important during homeostasis and disease processes. Prostaglandin E2 exhibits both 
pro- and anti-inflammatory effects. At the same time that PGE2 may induce cardinal 
signs of inflammation (i.e. pain, edema and fever), PGE2 may also exert strong anti-
inflammatory effects by suppressing production of pro-inflammatory cytokines and 
enhancing the synthesis of anti-inflammatory cytokines, such as IL-10 (Cheon et al., 
2006). This diversity in PGE2 actions is believed to be the result of four PGE receptor 
subtypes (EP1 to EP4) coupled to different signal transduction pathways (Minami et al., 
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2001). Most major cells involved in inflammation have these four subtypes of EP 
receptors, including lymphocytes (T and B), macrophages and dendritic cells. Depending 
on receptor subtype, cell population, and context of activation, PGE2 will exert pro- or 
anti-inflammatory effects. For instance, PGE2 interaction with EP4 enhances the 
migration of antigen-stimulated Langerhans cells to lymph nodes and subsequent T cell 
activation during hypersensitivity response. On the other hand, PGE2 inhibits the 
production of TNFα in macrophages through the EP4 receptor and T cell proliferation 
through the EP2 receptor (Park and Christman, 2006).       
Prostaglandins are synthetized from arachidonic acid, a fatty acid freed from 
phospholipids of cell walls trough action of the enzyme phospholipase A2 (PLA2), 
which, in the bovine endometrium, include PLA group IV (PLA2G4A and PLA2G4C) 
and group VI (PLA2G6; Herath et al., 2009). Tithof et al. (2007) using Western blot 
demonstrated that bovine endometrial epithelial cell production of PGF2α after oxytocin 
stimulation is mediated trough up-regulation of PLA2G6 protein expression and activity, 
whereas PGE2 biosynthesis was associated with PLA2G4C protein expression and 
activity. 
Cyclooxygenase enzymes, also known as prostaglandin-endoperoxide synthase 
(PTGS), convert arachidonic acid into PGH2, which is quickly converted into 
thromboxane, prostacyclin or prostaglandins D, E or F via the action of specific 
prostaglandin synthase (MacKenzie et al., 2013). Interestingly, in a study conducted by 
Herath et al. (2009), the switch in endometrial secretion of PGF2α to PGE after LPS 
challenge was associated with increased protein level of PLA2G6 rather than changes in 
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mRNA expression of specific prostaglandin synthase E and F. In this same study, levels 
of PLA2G4C protein were not affected by LPS. This effect of increased PLA2G6 after 
LPS challenge and accumulation of PGE is in contrast to what was reported by Tithof et 
al. (2007), in which the stimulation of PLA2G6 with oxytocin led to accumulation of 
PGF. Herath et al. (2009) speculated that the differences between studies may be a 
consequence of cell culture methods, the stage of ovarian cycle when the endometrial 
cells were collected, or differences between oxytocin and LPS challenge. Moreover, 
Herath et al. (2009) pointed out that in the experiment by Tithof et al. (2007), 
overexpression of PLA2G6 in epithelial cells resulted in oxytocin increasing the PGE to 
PGF ratio. 
Cyclooxygenase-1 (PTGS-1) and COX-2 (PTGS-2) are the main cyclooxygenase 
in mammalian cells, with COX-1 being constitutively expressed in most tissues, whereas 
COX-2 is upregulated in response to inflammatory stimuli. The promoter region of COX-
2 gene contains binding sites for several transcription factors, including NF-κB 
(MacKenzie et al., 2013). Lipopolysaccharide leads to the activation of NF-κB (Lu et al., 
2008), which may explain the increased expression of COX-2 mRNA and PG secretion 
by endometrial cell after LPS challenge (Herath et al., 2006). 
Effects of Endotoxin on Blood Cortisol and Haptoglobin Concentration 
Under stressful situations, the activity of the sympathetic nervous system is 
changed, leading to an increase in cardiovascular function and a release of adrenal 
catecholamines (Jansen et al., 1995). This phenomenon is known as the “fight or flight” 
response, which is essential for host survival. 
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During stressful situations such as endotoxemia, glucocorticoids play an 
important role in maintaining homeostasis because it prevents an exacerbated 
inflammatory response, which is essential for survival. Cortisol release is controlled by 
the hypothalamic-pituitary-adrenal (HPA) axis. According to Beishuizen and Thijs 
(2003), adrenalectomized mice had increased mortality after LPS, IL-1 or TNFα 
challenge, but adrenalectomized mice survived these challenges when glucocorticoid was 
administered. Glucocorticoids modulate the inflammatory response by suppressing pro-
inflammatory cytokines such as IL-1, IL-6, and TNFα, and by upregulating anti-
inflammatory cytokines such as IL-4 and IL-10.  
Glucocorticoids also reduce expression of adhesion molecules on endothelial cells 
through indirect and direct mechanisms (Barnes, 1998). Glucocorticoids indirectly reduce 
expression of adhesion molecules because they inhibit secretion of cytokines such as IL-
1β and TNFα, which are known to induce expression of adhesion molecules on 
endothelial cells. On the other hand, glucocorticoids inhibit gene transcription for ICAM-
1 and E-selectin, directly reducing expression of adhesion molecules (Cronstein et al., 
1992). 
The exact mechanism through which LPS and cytokines stimulates HPA axis is 
complex and still not completely understood. Lipopolysaccharides increase the levels of 
TNFα, IL-1 and IL-6 that stimulates secretion of corticotropin-releasing hormone by the 
hypothalamus, which stimulates secretion of adrenocorticotropic hormone (ACTH) by 
the pituitary. Adrenocorticotropic hormone stimulates the synthesis and secretion of 
glucocorticoids from the adrenal cortex. A direct effect of LPS on pituitary and adrenal is 
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also speculated because some studies demonstrated that LPS may stimulate 
corticosterone secretion after removal of the medial hypothalamus (Beishuizen and Thijs, 
2003).  
Vakharia and Hinson (2005) demonstrated that LPS stimulates cortisol secretion 
by human adrenocortical cell line NCI-H295R, a line of adrenocortical tumor cells. 
Because these cells express TLR2 and TLR4, it was suggested by the authors that these 
receptors mediate the effects of LPS in adrenal cells. 
Among the systemic consequences of endotoxemia, in response to increased 
secretion of pro-inflammatory cytokines, is the production by the liver of acute-phase 
proteins (APP). In ruminants, haptoglobin (Hp) is a major APP and has been suggested 
as a diagnostic marker for diseases such as mastitis and respiratory diseases (Hiss et al., 
2004). 
Haptoglobin is a plasma protein synthesized by hepatocytes that binds to free 
hemoglobin to prevent oxidative damage. Once bound to Hp, haemoglobin loses its 
oxidizing ability. Haptoglobin-haemoglobin complex is removed from the circulation 
through endocytosis after recognition by the receptor CD163 expressed by monocytes 
and macrophages (Carter and Worwood, 2007). 
Haptoglobin is a member of the APP family because its production is strongly 
increased by pro-inflammatory cytokines such as IL-6. Haptoglobin role on the immune 
system is still unclear, but it is speculated that Hp acts to regulate the immune responses 
with an anti-inflammatory activity (Huntoon et al., 2008). 
 In summary, cows with vaginal purulent discharge have impaired reproductive 
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performance but there is no product available in the United Stated for treatment of this 
disease. This dissertation describes and discusses experiments that evaluated the effects 
of treating cows with vaginal purulent discharge intrauterinally with an 
immunomodulator (E. coli LPS) on inflammatory/immune responses, uterine health, and 
reproductive performance. The main hypothesis of these experiments was that 
intrauterine treatment with E. coli LPS would induce local and systemic inflammatory 
responses leading to resolution of vaginal purulent discharge and improvements in 
reproductive performance of lactating dairy cows. 
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Figure 1. General structure for bacterial lipopolysaccharides. Abbreviations: KDO: 
3-deoxy-α-D-mannooctulosonic acid; Hep: Heptulose (ketoheptose); NGa: 
Galactosamine; NGc: Glucosamine. Source: Retrieved May 10, 2013, from the Sigma-
Aldrich Co website <http://www.sigmaaldrich.com/technical-
documents/articles/biology/glycobiology/lipopolysaccharides.html>. 
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Figure 2. Structure of a Toll-like receptor (TLR). Taken from: Kindt, T. J., R. A. 
Goldsby, B. A. Osborne, and J. Kuby. 2007. Kuby immunology, Figure 3-10. WH 
Freeman & Company. 
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 Chapter 2  
The Manuscript 
 
Effects of intra-uterine infusion with Escherichia coli lipopolysaccharide on 
endometrial mRNA gene expression, peripheral polymorphonuclear leukocyte 
activity, hemogram parameters, and cortisol, haptoglobin and progesterone 
concentrations of Jersey cows diagnosed with vaginal purulent discharge 
 
OVERVIEW 
The objectives of the current experiment were to investigate the effects of intra-
uterine treatment of cows with vaginal purulent discharge (VPD) with lipopolysaccharide 
(LPS) from Escherichia coli on endometrial mRNA expression of genes related to 
inflammatory responses; peripheral polymorphonuclear leukocytes (PMNL) function; 
hematological parameters; and circulating concentrations of cortisol, haptoglobin and 
progesterone. Jersey cows (n = 3,084) were examined for vaginal purulent discharge at 
31 ± 3 d postpartum using the Metricheck device.  Cows with at least 50% of pus in the 
exudate retrieved from the cranial vagina were characterized as positive for VPD. At 
examination, 2,664 cows were determined to be healthy, 310 cows were determined 
positive for VPD (10.1%), but only 267 cows with VPD were used in this experiment. 
Cows with VPD were balanced at 31 ± 3 d postpartum for lactation number, body 
condition score (BCS), VPD score (mild, moderate, severe), and weekly average milk 
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yield, and randomly assigned to the control treatment [intrauterine infusion of 20 mL of 
phosphate-buffered saline (PBS); n = 87] or to receive 20 mL of PBS containing 150 µg 
of LPS (LPS150; n = 91) or 300 µg of LPS (LPS300; n = 89) of E. coli LPS (E. coli 
serotype 026:B6, containing 10,000 endotoxin units per mg of LPS; Sigma-Aldrich, St. 
Louis, MO, USA). Lipopolysaccharide treatment occurred 24 h after diagnosis of VPD 
and enrollment. A sub-sample of cows had their endometrium biopsied 6 h after infusion 
and another sub-sample of cows had their endometrium biopsied 24 h after infusion to 
evaluate the effect of treatment on endometrial mRNA expression of genes related to 
inflammatory responses. Peripheral blood polymorphonuclear leukocyte expression of 
adhesion molecules [L-selectin and β2-Integrins (CD18)], phagocytosis and oxidative 
burst were evaluated immediately before treatment (0 h) and again at 2 and 6 h after 
treatment. Blood samples on 0, 2, 6, 24, and 48 h were used for hemogram; on 0, 2, 4, 6, 
and 24 h for determination of cortisol; and on 0, 24, 48 and 168 h for determination of 
haptoglobin and progesterone (P4) concentrations. There was no effect of treatment on 
endometrial mRNA expression of adhesion molecules [endothelial leukocyte adhesion 
molecule (E-selectin), intracellular adhesion molecule-1 (ICAM-1) and vascular cell 
adhesion molecule-1 (VCAM-1)], cytokines (tumor necrosis factor-α (TNF-α), IL-1β, IL-
6, IL-8 and IL-10) and Toll-like receptor-4 (TLR-4) in biopsies collected at 6 or 24 h 
after treatment. There was no effect of treatment on PMNL expression of L-selectin, but 
geometric mean fluorescence intensity (GMFI) of PMNL expressing CD18 was higher 
for LPS150 cows (5143.77 ± 248.17) than control cows (4208.69 ± 243.92) and tended to 
be higher in LPS150 than LPS300 cows (4505.66 ± 243.40). Cows enrolled in the 
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LPS300 treatment had greater percentage of PMNL positive for both, phagocytosis and 
oxidative burst (67.0% ± 1.46), compared to control (62.0% ± 1.50) and LPS150 (62.2% 
± 1.46) cows. There was no significant effect of treatment on hemogram parameters and 
circulating concentrations of cortisol, haptoglobin and progesterone (P4). These 
observations suggest that intrauterine infusion of E. coli LPS moderately stimulates 
circulating PMNL phagocytosis and expression of CD18 but it has no effect on 
endometrial expression of mRNA of genes related to the inflammatory response. Further 
research is needed to better understand the mechanisms by which LPS could act as an 
immunomodulator for treatment of VPD.  
 
INTRODUCTION 
Reproductive failure, the most important reason for involuntary culling of dairy 
cows (NAHMS, 2007), greatly affects profitability of the cattle industry. Endometritis, an 
inflammation of the inner layer of the uterus that is usually associated with bacterial 
infection, affects approximately 20% of postpartum dairy cows (Galvão, 2012) and 
compromises establishment of new pregnancies, reduces milk production and increases 
culling (Sheldon et al., 2009).  Percentage of endometritic cows pregnant after first 
postpartum AI may be reduced by as much as one third (Gilbert et al., 2005). Commonly 
isolated bacterium from the uterus of cows with endometritis include Arcanobacterium 
pyogenes, Escherichia coli, Prevotella melaninogenicus, Fusobacterium spp., 
Streptococcus spp., Staphylococcus spp., Pasteurella multocida, Clostridium spp., and 
Bacillus licheniformis (Williams et al., 2005). Immune deficiency is one of the most 
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important factors that predispose lactating dairy cows to uterine diseases (LeBlanc, 
2008). In cows that develop metritis and endometritis, phagocytic capacity of neutrophils 
isolated from peripheral blood increases from parturition to the third week postpartum, 
but the number and phagocytic ability of neutrophils recovered from the uterus declines 
from the first to the third week postpartum (Hammon et al., 2006; Mateus et al., 2002). 
The cause of such asynchrony between peripheral blood and uterine neutrophil activity 
has not been determined, but it is possible that the reduced counts of bacteria in the uterus 
and increased concentrations of progesterone (P4) may reduce the chemotactic stimulus 
to the uterus (Mateus et al., 2002). There are no products currently approved in the 
United States for treatment of endometritis. Intrauterine treatment of endometritic cows 
using 500 mg of cephapirin benzathine in 19 g ointment base (Metricure®, Intervet, 
Boxmeer, The Netherlands) is approved in Canada, Europe and New Zealand (Galvão, 
2012), and has been reported to improve reproductive performance of cows with clinical 
(LeBlanc et al., 2002) and subclinical (Kasimanickam et al., 2005) endometritis. 
However, cost of treatment associated with possible development of microbial resistance 
to antibiotics, makes interesting the idea of development of non-antimicrobial treatments 
that effectively improves fertility. Furthermore, intra-uterine antibacterial therapy may 
inhibit phagocytic activity of neutrophil in the uterus (Oxender and Seguin, 1976; 
Massera et al., 1980), which may compromise recovery from uterine infections.  
Lipopolysaccharide present in the outer membrane of gram-negative bacteria cell 
wall plays important role in pathogen recognition and triggering the subsequent 
inflammatory response (Mogensen, 2009) and has been used as an immunomodulator. In 
 36 
 
mammals, the physiological recognition of bacterial LPS occurs trough the Toll-like 
receptor-4 (TLR-4) in association with myeloid differentiation factor 2 (MD-2) (Park et 
al., 2009). After LPS binding to the complex TLR4-MD-2, TLR4 Toll-interleukin 1 
receptor (TIR) domain plays a critical role in signal transduction through protein-protein 
interactions among TLR-4 and five adaptor proteins, leading to the activation of 
transcription factors such as nuclear factor-κB (NF-κB)  and members of the interferon-
regulatory factor family (Lu et al., 2008; O’Neill and Bowie, 2007). Upon NF-κB 
activation, many cytokines such as tumor necrosis factor-α (TNF-α), IL-1, IL-6 and IL-8 
are produced (Wright, 1999), stimulating both innate and adaptive immunity (Li and 
Verma, 2002; Schroder et al., 2004). Interleukin-1 and TNF-α are functionally related 
pro-inflammatory cytokines that mediate many of the consequences of sepsis including 
fever, vasodilatation and stimulation of other cytokines (Marsh et al., 1994). Interleukin-6 
is a cytokine with both pro and anti-inflammatory properties. Acting as pro-inflammatory 
cytokine, IL-6 in association with IL-1β or TNF-α stimulates the production of various 
chemokines leading to the attraction of neutrophils in the initial phase of inflammation. 
However, by 24-48 h after initial infiltration, neutrophils are replaced by monocytes and 
T cells in order to prevent tissue damage from accumulation of proteases and reactive 
oxygen species produced by neutrophils. Within this context, IL-6 induces neutrophil 
apoptosis contributing to resolution of the acute neutrophil infiltration (Scheller et al., 
2011). Interleukin-6 also upregulates expression of adhesion molecules on endothelial 
cells and leukocytes (Scheller et al., 2011), induces acute-phase protein production by the 
liver (e.g. haptoglobin), and stimulates hematopoiesis (Kishimoto et al., 1992). 
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Furthermore, TNF-α, IL-1 and IL-6 stimulate secretion of glucocorticoids from the 
adrenal cortex. Increasing concentrations of cortisol prevents an exacerbated 
inflammatory response, which is essential for host survival (Beishuizen and Thijs, 2003). 
Interleukin-8, member of the chemokine family, plays an important role guiding 
leukocytes to sites of inflammation, increases neutrophil expression of integrin adhesion 
molecules LFA-1 (CD11aCD18) and MAC1 (CD11bCD18) and induces neutrophils to 
release lysosomal enzymes (Harada et al., 1994). Interleukin-10 possesses 
immunosuppressive and anti-inflammatory properties because it prevents antigen-specific 
T cell activation and down regulates the production of pro-inflammatory cytokines and 
chemokines in many cell types (de Vries, 1995). Moreover, adhesion molecules 
expressed on endometrial cells [endothelial leukocyte adhesion molecule (E-selectin), 
intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule 
(VCAM-1)] play a critical role in leukocyte-endothelium interactions allowing 
leukocytes to migrate to inflamed tissues (Kindt et al., 2007). Nuclear-factor κB also 
stimulates cyclooxygenase-2 (COX-2; MacKenzie et al., 2013), resulting in increased 
prostaglandins  being produced following LPS stimulus, which might interfere with the 
luteolysis process (Herath et al., 2006).  
The hypothesis of the current study is that intra-uterine treatment of cows with 
vaginal purulent discharge (VPD) with E. coli LPS will modulate endometrial mRNA 
expression of genes related to the inflammatory response, will increase PMNL activity 
(expression of adhesion molecules, phagocytosis and oxidative burst), will increase blood 
cortisol and haptoglobin concentrations, and, in cows with a corpus luteum (CL) present 
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in the ovary, will stimulate luteolysis. Our objectives were to investigate the effects of 
intra-uterine treatment of endometritic cows with LPS from E. coli on endometrial 
mRNA expression of genes related to the inflammatory response, circulating PMNL 
function, hematological parameters, and circulating concentrations of cortisol, 
haptoglobin and P4.  
 
MATERIAL AND METHODS 
Cows and Treatments 
The University of Minnesota Institutional Animal Care and Use Committee 
reviewed and approved all procedures. Jersey lactating cows (n = 3,084) from a free-stall 
dairy located in Nicollet, MN were evaluated for vaginal purulent discharge (VPD) at 31 
± 3 d postpartum using the Metricheck device (Simcro, New Zealand; McDougall et al., 
2007) from December 2010 to May 2012. Cows with > 50% of pus in the retrieved 
vaginal exudate were considered positive for VPD. At examination, 2,664 cows were 
determined to be healthy, and there were 420 (13.6%) cows with > 50% of pus in the 
retrieved exudate. These cows were examined by palpation per rectum of the uterine 
contents and 110 cows were determined to have large amounts of fluid accumulated in 
the uterus and therefore were not treated in the study. The remaining 310 cows were 
designated positive for VPD (10.1%), but only 267 cows were assigned to treatments 
because in each enrollment day cows were enrolled in the order that they found up to a 
maximum of 9 cows enrolled per day. Cows with VPD (n = 267) were balanced at 31 ± 3 
d postpartum for lactation number, BCS, VPD score (mild, moderate, severe), and 
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weekly average milk yield, and randomly assigned to the control treatment (intrauterine 
infusion of 20 mL of PBS (n = 87) or to receive an intrauterine infusion of 20 mL of PBS 
containing 150 µg of E. coli LPS (LPS150; n = 91) or to receive an intrauterine infusion 
of 20 mL of PBS containing 300 µg of E. coli LPS (LPS300; n = 89). 
Lipopolysaccharide was from E. coli serotype 026:B6 containing 10,000 endotoxin units 
per mg of LPS (Sigma-Aldrich, St. Louis, MO, USA). Lipopolysaccharide treatment 
occurred 24 h after diagnosis of VPD and enrollment. 
Vaginal Purulent Discharge Score  
Scores for VPD were given based on visually observation of retrieved exudate, 
which was placed on a black plastic plate to improve visualization. Scores were given 
according to the following classification: mild (retrieved exudate contained 
approximately 50 to 60% of pus); moderate (retrieved exudate contained approximately 
60 to 90% of pus); and severe (retrieved exudate contained approximately 90 to 100% 
pus). 
General Cow Management 
All cows were milked thrice daily and were fed a fresh TMR twice daily. With 
respect to the reproductive management, voluntary waiting period was 50 DIM and cows 
were inseminated when observed in estrus after the end of the voluntary waiting period. 
Cows were presynchronized with three injections of prostaglandin (PG) F2α given 41 ± 3, 
55 ± 3 and 69 ± 3 DIM. Cows not inseminated in estrus were enrolled in the Ovsynch56 
protocol (GnRH, 7 d later PGF2α, 56 h later GnRH) 81 ± 3 DIM and were inseminated at 
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fixed time 91 ± 3 DIM. As for resynchronization of the estrous cycle of non-pregnant 
cows, cows enrolled in the study from December 2010 to September 2011 received the 
first GnRH of the Ovsynch56 protocol at 31 ± 3 d after insemination and if diagnosed not 
pregnant 38 ± 3 d after AI, received a PGF2α injection at non-pregnancy diagnosis, GnRH 
56 h later, and TAI 16h later. Cows enrolled in the study from February 2012 to May 
2012 were examined by ultrasound (5 MHz, Ibex Lite; E. I. Medical Imaging, Loveland, 
CO) for pregnancy diagnosis at 31 ± 3 d after AI and non-pregnant cows were enrolled in 
one of two resynchronization protocols depending on ovarian structures present in the 
ovaries at the time of non-pregnancy diagnosis. Cows that had a CL > 20 mm in diameter 
received an injection of PGF2α, and if not inseminated in estrus in the following 12 d were 
enrolled in the Ovsynch56. Cows that at non-pregnancy diagnosis did not have a CL > 20 
mm in diameter received a GnRH injection at non-pregnant diagnosis and were enrolled 
in the Ovsynch56 protocol 7 d later. Cows diagnosed pregnant at 31 ± 3 or 38 ± 3 d after 
AI were re-examined 66 ± 3 and 184 ± 3 d after AI. 
Endometrial Biopsies 
A sub-sample of cows (control, n = 16; LPS150, n = 17; LPS300, n = 17) had 
their endometrium biopsied 6 h after infusion and another sub-sample of cows (control, n 
= 18; LPS150, n = 17; LPS300, n = 14) had their endometrium biopsied 24 h after 
infusion. Biopsies were collected as described by Galvão et al. (2011). Briefly, before 
collecting biopsy samples, an epidural anesthesia (4 mL of 2% lidocaine) was performed. 
Samples were collected using a Hauptner biopsy instrument that was protected with a 
sanitary chemise (IMV Technologies, L'Aigle, France), which was broken immediately 
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before the biopsy tool was passed through the cervical os. Biopsies (weighed between 
100 and 200 mg) were collected from the base of the larger horn (whenever it was 
possible to distinguish), which was presumed to be the previously gravid horn, and 
placed in 2 ml microcentrifuge tubes containing 1 mL of a commercial sample buffer 
(RNAlater®, Ambion-Applied Biosystems, Life Technologies Corporation, Carlsbad, 
CA, USA) and frozen at -80°C until RNA isolation. 
RNA Isolation and Purification 
RNA isolation and purification was done as described by Cerri et al. (2012). 
Briefly, endometrial samples were removed from the -80°C freezer and kept on shaved 
ice until extraction. The RNA was extracted using TRIzol reagent (Invitrogen Corp., 
Carlsbad, CA) and purified using PureLink™ RNA Mini Kit (Invitrogen Corp., Carlsbad, 
CA) according to the manufacturer's protocol. The RNA concentration, purity and 
integrity were determined using the Agilent 2100 Bioanalyzer Nano Drop 2000 
Spectrophotometer (Thermo Scientific, Wilmington, DE, USA). Samples were aliquoted 
and stored at -80°C until amplification. 
Quantitative, Real-Time, Reverse Transcription-PCR 
Quantitative RT-PCR was performed using Applied Biosystems 7500 Real-Time 
PCR system (Applied Biosystems, Life Technologies Corporation) as described 
previously (Ozawa et al., 2013). Briefly, RNA samples (50 ng/reaction) were incubated 
with RNase-free DNase I (New England BioLabs, Ipswich, MA) for 15 min at 37°C, heat 
denatured (75°C for 10 min), and then reverse transcribed using High Capacity cDNA 
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Reverse Transcription Kit and random hexamers (Applied Biosystems) and amplified 
with SYBR Green PCR Master Mix reagent (Applied Biosystems) under PCR normal 
conditions (40–50 cycles of 95°C for 15 s and 60°C for 1 min). Primers used in the 
current experiment were designed using Primer Express v2.0 (Applied Biosystems) and 
are shown in Table 1. Mitochondrial ribosomal protein S15 (MRPS15) was used as 
housekeeping gene as this has been shown to be the most stable normalizer gene in 
postpartum cows (Chapwanya et al., 2009). A standard curve was built for each gene of 
interest by doing four 1:5 dilutions starting with 100 ng/μL of cDNA solution. The 
efficiency of the amplification was calculated, and only primer sets with efficiency > 
90% were used. Specificity of amplification of each primer set was examined by 
dissociation curve analysis, and only sets with one single peak were used. All reactions 
were done in triplicate, and triplicate samples with Ct coefficient of variation > 1% were 
repeated. A no template control was run for each primer used on every 96-well plate. 
Fold change (n-fold) in gene expression was calculated using the relative quantitation 
method (2-ddCt) in which MRPS15 was used as endogenous control and the average delta 
Ct of samples collected from cows that received intrauterine infusion with PBS as the 
calibrator for each sample. 
Peripheral Polymorphonuclear Cell Activity  
Ex vivo innate immune parameters were evaluated from a sub-group of 25 cows 
per treatment at 0, 2, and 6 h relative to treatment as described by Hulbert et al. (2011). 
Samples were collected into heparinized evacuated tubes (Becton Dickinson Vacutainer 
Systems, Franklin Lakes, NJ, USA). Expression of leukocyte adhesion molecule-1 (L-
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selectin) and CD18 by peripheral PMNL was determined by indirect 
immunofluorescence staining. Briefly, the assay consisted of incubating 200 μL of whole 
blood at 4°C for 30 min with 5 μg/mL of anti-bovine CD62L (DU1-29, VMRD Inc., 
Pullman, WA) monoclonal antibody produced in mouse or 2.5 μg/mL of anti-bovine 
CD18 (BAQ30A, VMRD Inc., Pullman, WA, USA) monoclonal antibody produced in 
mouse. Prior to the incubation of cells with an anti-mouse IgG-FITC secondary 
polyclonal antibody (AbD Serotec, Raleigh, NC, USA) diluted 1:400 in PBS solution 
(Sigma-Aldrich, St. Louis, MO, USA), erythrocytes were lysed with hypotonic PBS 
solution. After washing the cells with PBS solution, samples were analyzed by flow 
cytometry. Blood from non-diseased cows were used as positive and negative controls in 
all assays. Negative controls consisted of incubating 200 μL of PBS solution instead of 
the monoclonal antibody. Phagocytic and oxidative burst activity of peripheral PMNL 
were determined upon challenge with enteropathogenic bacteria (E. coli 0118:H8) as 
previously described by Hulbert et al. (2011). Briefly, the assay to determine 
phagocytosis and oxidative burst consisted of incubating 200 µL of whole blood with 100 
µM of dihydrorhodamine 123 (Molecular Probes, Invitrogen, USA), an oxidative-
sensitive indicator, and 40 µL of fluorescently labeled bacteria (109 cfu/mL) at 38.5°C for 
15 min, with surface bacteria fluorescence removed using the Trypan Blue Solution 
(0.4%; Sigma-Aldrich, St. Louis, MO, USA). After washing with milliQ water to remove 
excess dye, erythrocytes were lysed by the addition of hyper-concentrated PBS solution 
(Sigma-Aldrich, St. Louis, MO, USA). Lastly, the cells were resuspended in PBS 
solution for immediate flow cytometry analysis. Blood from non-diseased cows were 
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used as positive and negative controls. Unlabeled bacteria were used as negative controls 
for the phagocytosis assay and samples that received no dihydrorhodamine 123 served as 
negative controls for the oxidative burst assay. All flow cytometry data were collected on 
a BD FACSCANTO II (BD Biosciences, Franklin Lakes, NJ, USA) and analyzed using 
FlowJo 7.6.4 software (Tree Star Inc., San Carlos, CA, USA). The PMNL population was 
identified on basis of forward and side scattered properties. After strictly gating the 
PMNL population, data from 3 parameters were collected for analysis: forward scatter, 
side scatter, and log fluorescence. Intensity of phagocytosis, oxidative burst, and 
expression of CD18 and L-selectin molecules by PMNL was expressed in geometric 
mean fluorescence intensity (GMFI). Intensity of phagocytosis and expression of 
adhesion molecules were an indirect indication of the number of phagocytised bacteria 
and antibody against CD62L or CD18 adhere to PMNL, respectively. Oxidative burst 
intensity was an indirect indication of the amount of reactive oxygen species produced 
via oxidation of dihydrorhodamine 123. Furthermore, percentages of PMNL positive for 
phagocytosis, oxidative burst, and expression of CD18 and L-selectin molecules were 
calculated. 
Hemogram 
Blood samples on 0, 2, 6, 24, and 48 h after treatment were collected from a sub-
group of cows (control, n = 38; LPS150, n = 40; LPS300, n = 41) for hemogram. Samples 
collected into evacuated tubes with K3 EDTA (Becton Dickinson Vacutainer Systems, 
Franklin Lakes, NJ, USA) were analysed using a Vet Scan HM2 (Abaxis, Union City, 
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CA). Complete blood count was performed but only data referent to counts of leukocytes, 
lymphocytes, monocytes and granulocytes are reported. 
 
Cortisol, Haptoglobin and Progesterone Assays 
For determination of concentrations of cortisol, haptoglobin and P4 blood was 
sampled (7 mL) from the median coccygeal vein or artery using evacuated tubes and 
immediately placed in ice and transported to the laboratory within 5 h of collection. 
Blood tubes were centrifuged at 2,000 × g for 15 min for serum or plasma separation. 
Serum and plasma samples from individual cows were frozen at -25°C until analyzed.  
For determination of cortisol concentration, blood samples from a sub-group of 
cows (control, n = 43; LPS150, n = 45; LPS300, n = 42) were collected into evacuated 
tubes without anticoagulant (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ, 
USA) at 0, 2, 4, 6, and 24 h relative to treatment, and serum was analysed using a solid-
phase radioimmunoassay kit (Coat-a-Count, Siemens Medical Solutions Diagnostics, Los 
Angeles, CA, USA). The intra- and inter-assay coefficients of variation (CV) were 9.32% 
and 3.59%, respectively.  
Haptoglobin concentration was determined by a colorimetric procedure (Hulbert 
et al., 2011) using a plate reader (Spectramax 340; Molecular Devices, Sunnyvale, CA) to 
measure absorbance. Samples were collected into evacuated tubes without anti-coagulant 
(Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ, USA) 0, 1, 2, and 7 d after 
treatment from all cows. The intra-assay and inter-assay CV were 4.64 and 3.55%, 
respectively. 
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Blood samples for determination of P4 concentration were collected from all 
cows on d 0, 1, 2, and 7 after treatment into evacuated tubes containing EDTA (Becton 
Dickinson Vacutainer Systems, Franklin Lakes, NJ, USA). All samples collected on d 0 
were analyzed for P4 concentration and cows with P4 ≥ 1 ng/mL were classified as 
having a CL present in the ovary at the time of treatment. Cows with P4 > 1 ng/mL on d 
0 had samples collected on d 1, 2 and 7 analyzed for P4 concentration to determine if 
LPS treatment stimulated luteolysis. Progesterone concentration in plasma was 
determined by RIA (Coat-a-Count Progesterone, Siemens Medical Solutions Diagnostics, 
Los Angeles, CA) and the intra-assay and inter-assay CV were 7.28 and 6.46%, 
respectively. 
Statistical Analysis 
The design of the experiment was complete randomized with cows balanced for 
lactation number, BCS, VPD score, and weekly average milk yield. All statistical 
analyses were conducted using SAS (SAS Institute Inc., Cary, NC).  
For endometrial mRNA gene expression, UNIVARIATE procedure revealed that 
n-fold was not normally distributed; therefore, ANOVA was performed on the delta delta 
Ct (ddCt) values using GLM procedure. Fold change values were used to present the 
data.  
Data of peripheral PMNL function, hemogram, and concentrations of cortisol, 
haptoglobin and P4 were analyzed by ANOVA for repeated measures using MIXED 
procedure. All models included treatment, time, treatment by time interaction and the 
baseline value as a covariate (0 h or 0 d). Baseline data were analyzed by ANOVA using 
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GLM procedure. Because of the possible effects of endometrial biopsy on cortisol and 
haptoglobin concentrations, whether or not the cow was biopsied and time that biopsy 
was collected (6 or 24 h after treatment) were included in the model (0 = no biopsy; 6 = 
biopsy 6 h; 24 = biopsy 24 h). Cortisol, haptoglobin and P4 data were not normally 
distributed and therefore statistical analysis was performed using log to the base 10 of 
original values, but data are presented as back transformed values. Finally, proportion of 
cows assumed to have a CL present in the ovary (P4 > 1 ng/mL) at moment of treatment, 
and proportion of cows that had luteolysis following treatment were analyzed by Fisher’s 
Exact Test using FREQ procedure in samples collected at d 0 and on d 1, 2 and 7 after 
treatment. 
Statistical significance was defined as P < 0.05 and statistical tendencies as 0.05 < 
P < 0.10. 
 
RESULTS 
Endometrial Biopsies 
Endometrial mRNA expression of adhesion molecules (E-selectin, ICAM-1 and 
VCAM-1), cytokines (TNF-α, IL-1β, IL-6, IL-8 and IL-10), and TLR-4 at 6 h (Figure 3) 
and 24 h (Figure 4) after treatment were not (P > 0.25) affected by treatment.  
Peripheral Blood Polymorphonuclear Cell Activity 
Percentage of PMNL positive for expression of L-selectin (P = 0.74) and intensity 
of expression of L-selectin (P = 0.80) were not affected by treatment (Table 2). 
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Percentage of PMNL positive for expression of CD18 was not affected by treatment (P = 
0.76). Geometric mean fluorescence intensity of expression of CD18 was higher for 
LPS150 than control cows (P = 0.01) and tended to be higher for LPS150 than LPS300 
cows (P = 0.07), but there was no difference between control and LPS300 cows (P = 
0.39; Table 2). 
Percentage of PMNL positive for phagocytosis and oxidative burst were affected 
by treatment (P = 0.03; Table 2, Figure 5), which was higher in LPS300 cows (67.00%) 
than in control (61.95%; P = 0.02) and LPS150 cows (62.23%; P = 0.02). Moreover, 
there was no effect of treatment in GMFI for phagocytosis (P = 0.35) and oxidative burst 
(P = 0.64) in PMNL positive for both phagocytosis and oxidative burst (Table 2).   
Hemogram 
Selected results of hemogram analysis are shown in Table 3. Treatment had no 
effect on counts of leukocytes (P = 0.63), granulocytes (P = 0.56), lymphocytes (P = 
0.21) and monocytes (P = 0.35). Granulocyte to lymphocyte ratio was also not (P = 0.25) 
affected by treatment (Figure 6). 
Cortisol, Haptoglobin and Progesterone Assays  
Cortisol (P = 0.72; Figure 7) and haptoglobin (P = 0.89; Figure 8) concentrations 
were not affected by treatment. Furthermore, the interactions between treatment and 
sample did not affect cortisol (P = 0.12) and haptoglobin (P = 0.26) concentrations. 
Proportion of cows with P4 > 1.0 ng/mL 0 h relative to treatment was not 
different (P = 0.55) among treatments [control = 51.72% (45/87); LPS150 = 43.96% 
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(40/91); LPS300 = 44.94% (40/89)]. Moreover, within cows with P4 > 1.0 ng/mL at 
moment of treatment, the proportion of cows that had luteolysis P4 < 1.0 ng/mL at d 1 [P 
= 0.42; control = 13.33% (6/45); LPS150 = 12.50% (5/40); LPS300 = 22.50% (9/40)], d 
2  [P = 0.36; control = 11.11% (5/45); LPS150 = 15.00% (6/40); LPS300 = 22.50% 
(9/40)] and d 7 [P = 0.95; control = 51.11% (23/45); LPS150 = 51.28% (20/39); LPS300 
= 47.50% (19/40)] were also not affected by treatment. Furthermore, there was no (P = 
0.33) effect of treatment on P4 concentration following treatment (Figure 9). Lower 
concentrations of P4 at d 7 were expected because cows received a prostaglandin 
injection at 41 ± 3 d postpartum as part of the reproductive program. 
 
DISCUSSION 
It was expected that treatment of cows with VPD with LPS would alter the pattern 
of endometrial mRNA expression of genes for adhesion molecules, cytokines and TLR-4 
compared to control cows, but this was not observed in the present study. One possibility 
that would explain this outcome is that by 6 and 24 h after treatment mRNA gene 
expression that was initially upregulated was already downregulated. In a study 
conducted by Schmitz et al. (2004) mRNA expression of TNF-α in mammary biopsy 
samples of quarters intramammarily infused with LPS peaked at 3 h after treatment, and 
by 12 h, TNF-α mRNA expression was near baseline values. Another possibility for no 
differences in endometrial mRNA expression of genes related to inflammatory response 
in the present study could be attributed to the population used in the study, which were 
cows  believed to have clinical endometritis according to Sheldon et al. (2006) disease 
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definition. Endometritic cows are known to have the uterus colonized by both gram-
negative and gram-positive aerobes and anaerobes (Azawi, 2008), and LPS is the major 
component of the outer membrane of gram-negative bacteria cell wall. Galvão et al. 
(2011) evaluated endometrium mRNA gene expression of pro-inflammatory (TNFα, IL-
1β, IL-6 and IL-8) and anti-inflammatory (IL-10) cytokines in cows that developed 
endometritis and in healthy cows at weeks 1, 3, 5 and 7 after calving. They observed that 
mRNA gene expression for pro-inflammatory cytokines (IL-1β, IL-6 and IL-8) was 
increased in endometritic cows on weeks 5 and/or 7 after calving compared with healthy 
cows. Thus, one limitation of the present study is that uterine biopsies were not collected 
from healthy cows as it is possible that the lack of differences in expression of 
endometrial mRNA for pro-inflammatory genes between control and LPS treated cows 
may have been because all cows enrolled already had an up-regulation of these genes. 
Furthermore, endometrial mRNA expression of adhesion molecules 6 and 24 h after 
intrauterine infusions with PBS or LPS was not different. E-selectin is a cell adhesion 
molecule member of the selectin family that through interactions with its ligand 
expressed on the surface of leukocytes (L-selectin) is responsible for the initial stickiness 
of leukocytes to endothelium, an early step in the recruitment of these cells to a site of 
injury or inflammation (Springer,  1990). In addition, surface glycoprotein ICAM-1 
expressed by endometrial cells through interaction with its ligand CD11aCD18 expressed 
by leukocytes promotes leukocytes’ firm adhesion and diapedeses during leukocyte 
emigration from the bloodstream to extravascular tissues (Carlos and Harlan, 1994). 
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Although no differences among treatments were observed regarding PMNL 
expression of L-selectin, LPS150 cows had greater intensity of expression of CD18 than 
control cows. This increased expression of CD18 in LPS150 cows could result in 
improved migratory capacity of PMNL from the blood to the uterus. Endometritic cows 
treated with 150 µg of LPS had numerically higher counts of PMNL in uterine cytology 
than control and LPS300 cows in samples collected 24 and 48 h after intra-uterine 
infusion (Moraes et al., 2012a).  
Polymorphonuclear leukocyte phagocytosis and oxidative burst were partially 
affected by treatment. Non-specific phagocytosis by neutrophils is one of the most 
important lines of defense against establishment of uterine infections (LeBlanc, 2008). In 
the present study, LPS300 cows had greater percentage of PMNL positive for 
phagocytosis and oxidative burst than control and LPS150 cows. It was expected that 
LPS treated cows would have greater oxidative burst than control cows, as activation of 
cell NADPH oxidase, an important enzyme responsible for generating large amounts of 
superoxide during the oxidative burst process, can be induced by LPS, by lipoproteins, or 
by cytokines such as IFN-γ, IL-1β, and IL-8 (Droge, 2002). Moreover, no alterations on 
hemogram parameters were observed as consequence of LPS intra-uterine infusion. 
Intramammary challenge with 1,000 µg of LPS resulted in leukopenia 6 to 12 h after 
treatment (NADIR 6 h after treatment) and a peak concentration of immature neutrophils 
in the circulation 6 h after LPS treatment (Mehrzad et al., 2001). However, leukocytosis 
was observed from 24 to 48 h after intramammary infusion with LPS (Mehrzad et al., 
2001). Furthermore, circulating concentration of leukocytes was greater in LPS treated 
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cows compared with control cows by 216 h after treatment. In the present study, 
granulocyte to lymphocyte ratio was numerically higher for LPS treated cows than 
control cows, and granulocyte to lymphocyte ratio peaked 6 h after treatment and was 
still numerically higher by 48 h. 
Blood cortisol concentrations were not affected by treatment. Lipopolysaccharide 
increases concentrations of TNFα, IL-1 and IL-6, which stimulate the secretion of 
corticotropin-releasing hormone by the hypothalamus resulting in secretion of 
adrenocorticotropic hormone (ACTH) by the pituitary and glucocorticoids by the adrenal 
cortex (Beishuizen and Thijs, 2003). The lack of differences among treatments regarding 
cortisol concentration may result from handling induced stress during sample collection 
since all cows had a significant rise in cortisol concentration 4 to 6 h after intra-uterine 
infusions. Concentrations of haptoglobin were not different among treatments. Similarly, 
concentrations of the acute phase protein alpha-1 acid glycoprotein was not different 
between Holstein heifers receiving intrauterine infusion of 3 µg/kg of LPS (dose superior 
than higher dose used in the present study) or PBS (Williams et al., 2008). On the other 
hand, Hiss et al. (2004) reported significant increase in circulating haptoglobin 
concentrations 12 h after administration of 100 µg of LPS in the jugular vein of lactating 
dairy cows. Plasmatic concentration of LPS following challenge was not measured in the 
present study, but we speculate that the increase in haptoglobin concentration observed 
by Hiss et al. (2004) might be due to higher LPS concentration because of intravenous 
administration.   
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The lack of differences in percentages of cows with progesterone concentration > 
1 ng/mL at moment of intra-uterine infusion is important because progesterone is 
immunosuppressant (Siiteri et al., 1977; Hansen, 2013). Expression of mRNA for pro-
inflammatory chemokines and cytokines (CXCL5, IL-1β, and IL-8) are reduced during 
the diestrus compared with the proestrus (Fischer et al., 2010). Moreover, progesterone 
inhibits in vitro endometrial and epithelial production of PGE and PGF series in response 
to LPS challenge (Herath et al., 2006) and PG play a key role in the regulation of the 
inflammatory response (Ricciotti and FitzGerald, 2011). Among cows with CL present in 
the ovary in the current study, cows treated with LPS had numerically lower 
concentrations of P4 at d 1 and 2 after treatment. Moreover, the proportion of cows with 
P4 < 1 ng/mL at d 1 and 2 were numerically higher in LPS300 cows. Thus, we speculate 
that some cows might have initiated the process of luteolysis due increases in PGF 
secretion, and that this one week with lower progesterone concentrations before cows 
received the PGF2α of the synchronization protocol, might have contributed for better 
immune function in the uterus. Intrauterine treatment of cows with VPD with 150 µg or 
300 µg of LPS improved pregnancy at first postpartum artificial insemination compared 
to cows with VPD treated with just PBS, and pregnancy by 200 days postpartum was also 
greater for cows with VPD that were treated with 150 µg of LPS than cows with VPD 
treated with PBS (Moraes et al., 2013a). Thus, we believe that the sum of findings PMNL 
function, numerical differences in circulating leukocytes and reduction in progesterone 
concentration in cows with CL present in the ovary following LPS treatment, might have 
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contributed to improved reproductive performance that we observed (Moraes et al., 
2013a).  
 
CONCLUSIONS 
Treatment of cows with VPD with intrauterine infusion of E. coli LPS moderately 
stimulated circulating PMNL phagocytosis and expression of CD18 molecule, but had no 
significant effect on endometrial mRNA expression of inflammatory genes, hemogram 
parameters, and cortisol, haptoglobin or progesterone concentrations. The sum of 
findings of the present study contributed to understanding pathways by which LPS could 
be acting as an immunomodulator, as data from our group suggest improved reproductive 
performance in endometritic cows upon intrauterine treatment with LPS.  However, these 
findings are relatively weak to explain the big difference in reproductive performance 
that we observed, therefore further research is needed in order to better understand the 
inflammatory and immune mechanisms of E. coli LPS in the uterus of dairy cows 
diagnosed with VPD. 
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Figure 3. Effect of treatment on endometrium mRNA expression of adhesion molecules, 
cytokines and Toll-like receptor 4 (TLR-4) in endometrium biopsies collected 6 h after 
infusion. Treatments: Control (n = 16) - cows with vaginal purulent discharge (VPD) that 
received intrauterine infusions of 20 mL of PBS as treatment; LPS150 (n = 17) - cows 
with VPD that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. 
coli LPS as treatment; LPS300 (n = 17) - cows with VPD that received intrauterine 
infusions of 20 mL of PBS containing 300 µg of E. coli LPS as treatment.   Treatment 
had no effect on endometrial mRNA expression of E-selectin (P = 0.28), ICAM-1 (P = 
0.43), VCAM-1 (P = 0.38), TNF-α (P = 0.61), IL-1β (P = 0.45), IL-6 (P = 0.79), IL-8 (P 
= 0.33), IL-10 (P = 0.83) and TLR-4 (P = 0.25). 
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Figure 4. Effect of treatment on endometrium mRNA expression of adhesion molecules, 
cytokines and Toll-like receptor 4 (TLR-4) in endometrium biopsies collected 24 h after 
infusion. Treatments: Control (n = 18) - cows with vaginal purulent discharge (VPD) that 
received intrauterine infusions of 20 mL of PBS as treatment; LPS150 (n = 17) - cows 
with VPD that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. 
coli LPS as treatment; LPS300 (n = 14) - cows with VPD that received intrauterine 
infusions of 20 mL of PBS containing 300 µg of E. coli LPS as treatment. Treatment had 
no effect on endometrial mRNA expression of E-selectin (P = 0.60), ICAM-1 (P = 0.77), 
VCAM-1 (P = 0.73), TNF-α (P = 0.44), IL-1β (P = 0.37), IL-6 (P = 0.48), IL-8 (P = 
0.70), IL-10 (P = 0.91) and TLR-4 (P = 0.40).    
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Figure 5. Effect of treatment on percentage of peripheral blood PMNL positive for 
phagocytosis and oxidative burst. Treatments: Control (n = 25) - cows with vaginal 
purulent discharge (VPD) that received intrauterine infusions of 20 mL of PBS as 
treatment; LPS150 (n = 25) - cows with VPD that received intrauterine infusions of 20 
mL of PBS containing 150 µg of E. coli LPS as treatment; LPS300 (n = 25) - cows with 
VPD that received intrauterine infusions of 20 mL of PBS containing 300 µg of E. coli 
LPS as treatment. No difference among treatments (P = 0.27) in percentage of PMNL 
positive for phagocytosis and oxidative burst were observed in the sample collected 
before treatment, but it was higher (P = 0.03) in LPS300 cows than control cows at 2 h; 
higher in 300LPS (P = 0.01) than 150LPS cows at 6 h; and tended (P = 0.07) to be higher 
in 300LPS than control cows at 6 h. Furthermore, there was no interaction of treatment 
by sample (P = 0.23). 
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Figure 6. Effect of treatment on granulocyte to lymphocyte ratio. Treatments: Control (n 
= 38) - cows with vaginal purulent discharge (VPD) that received intrauterine infusions 
of 20 mL of PBS as treatment; LPS150 (n = 40) - cows with VPD that received 
intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS as treatment; 
LPS300 (n = 41) - cows with VPD that received intrauterine infusions of 20 mL of PBS 
containing 300 µg of E. coli LPS as treatment. There was no effect of treatment (P = 
0.25) on granulocyte to the lymphocyte ratio, and there was no interaction (P = 0.99) of 
treatment by sample. 
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Figure 7. Effect of treatment on blood cortisol concentration. Cortisol concentrations are 
expressed in back transformed values from logarithm to the base 10 of original results. 
Treatments: Control (n = 43) - cows with vaginal purulent discharge (VPD) that received 
intrauterine infusions of 20 mL of PBS as treatment; LPS150 (n = 45) - cows with VPD 
that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS as 
treatment; LPS300 (n = 42) - cows with VPD that received intrauterine infusions of 20 
mL of PBS containing 300 µg of E. coli LPS as treatment. There were no differences 
among treatments on cortisol concentrations at baseline (P = 0.48) or thereafter (P = 
0.72) and there was no interaction (P = 0.12 ) of treatment by sample. 
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Figure 8. Effect of treatment on blood haptoglobin concentration. Haptoglobin 
concentrations are expressed in back transformed values from logarithm to the base 10 of 
original results. Treatments: Control (n = 87) - cows with vaginal purulent discharge 
(VPD) that received intrauterine infusions of 20 mL of PBS as treatment; LPS150 (n = 
91) - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 150 
µg of E. coli LPS as treatment; LPS300 (n = 89) - cows with VPD that received 
intrauterine infusions of 20 mL of PBS containing 300 µg of E. coli LPS as treatment. 
There was no difference among treatments on haptoglobin concentrations at baseline (P = 
0.12) or thereafter (P = 0.89), and there was no interaction of treatment by sample (P = 
0.26). 
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Figure 9. Effect of treatment on progesterone (P4) concentration of cows that had P4 > 1 
ng/mL in the sample collected right before treatment. Progesterone concentrations are 
expressed in back transformed values from logarithm to the base 10 of original results. 
Treatments: Control (n = 87) - cows with vaginal purulent discharge (VPD) that received 
intrauterine infusions of 20 mL of PBS as treatment; LPS150 (n = 91) - cows with VPD 
that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS as 
treatment; LPS300 (n = 89) - cows with VPD that received intrauterine infusions of 20 
mL of PBS containing 300 µg of E. coli LPS as treatment. There was no statistical 
difference (P = 0.33) in progesterone concentration following treatment in cows with CL 
present in the ovary (P4 > 1 ng/mL) at moment of infusion, and there was no interaction 
of treatment by sample (P = 0.68). 
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Table 1. Gene used for quantitative reverse transcription-PCR. 
Gene  GenBank ID Primer Sequence (5’ to 3’) 
MRPS15  NM_001192201.1 Forward AGATGACCCGCCCCCTTCCA 
  Reverse GGGAGCTGGTGTCCTTCGGGT 
E-selectin NM_174181.2 Forward AGGCCACTCGGTGCATGTCC 
  Reverse CAACCTGGGTTGGCCCCTGC 
ICAM-1 NM_174348.2 Forward GGGCCTGCCGTGCTCCTTAC 
  Reverse AACAGCCCTCCCCTCCGGTC 
VCAM-1 NM_174484.1 Forward AGGGCTCAGTTAGAGGATGCGGG 
  Reverse CAAGGAAGCCTGAACCCCCAGT 
TNF-α NM_173966.2 Forward ACACACCCCCGAGAGACAGCC 
  Reverse TGGGGGCCGATTACCCCGAA 
IL-1β NM_174093.1 Forward GCTTCAGGCAGGTGGTGTCGG 
  Reverse GCACGGGTGCGTCACACAGA 
IL-6 NM_173923.2 Forward ATTCGCTGTCTCCCTGGGGCT 
  Reverse AGTCTGCCTGGGGTGGTGTCAT 
IL-8 NM_173925.2 Forward TGGCTGTTGCTCTCTTGGCAGC 
  Reverse CCTGCACAACCTTCTGCACCCA 
IL-10 NM_174088.1 Forward GAGAGTCTTCAGTGAGCTCCAAGAG
  Reverse GCATCTTCGTTGTCATGTAGGTTT 
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Table 2. Effect of intra-uterine infusion with LPS or PBS on PMNL expression of adhesion molecules (L-selectin and CD18), phagocytosis 
and oxidative burst 0, 2, and 6 h after infusion. 
P-value 
Items Control1 LPS1501 LPS3001 TRT Sample TRT x Sample 
PMNL expressing L-selectin, % 51.94 ± 3.60 55.94 ± 3.66 53.81 ± 3.61 0.74 0.35 0.58 
Intensity of L-selectin expression, GMFI 930.75 ± 53.09 904.70 ± 53.89 880.86 ± 53.28 0.80 0.33 0.51 
PMNL expressing CD18, % 95.87 ± 1.57 97.45 ± 1.58 97.05 ± 1.56 0.76 0.33 0.15 
Intensity of CD18 expression, GMFI 4208.69 ± 243.92a 5143.77 ± 248.17b,A 4505.66 ± 243.40B 0.03 0.54 0.35 
 
PMNL phago. and oxid. burst positive, %  61.95 ± 1.50a 62.23 ± 1.46a 67.00 ± 1.46b 0.03 < 0.01 0.23 
Intensity of phagocytosis, GMFI 3268.49 ± 98.63 3067.90 ± 96.37 3189.82 ± 96.81 0.35 0.01 0.20 
Intensity of oxidative burst, GMFI 7746.60 ± 471.62 7143.07 ± 459.55 7601.14 ± 462.79 0.64 0.22 0.22 
a,b Within a row, numbers with different lowercase letters (a,b) are different (P < 0.05). 
A,B Within a row, numbers with different uppercase letters (A,B) tended (0.05 < P < 0.10) to be different. 
1 Treatments: Control (n = 25) - cows with vaginal purulent discharge (VPD) that received intrauterine infusions of 20 mL of PBS as 
treatment; LPS150 (n = 25) - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS as 
treatment; LPS300 (n = 25) - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 300 µg of E. coli LPS as 
treatment. 
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Table 3. Effect of treatment on hemogram parameters. 
 Treatment  P - value 
Parameters, 109/L ± SEM1 Control2 LPS1502 LPS3002  TRT Sample TRT x Sample 
White blood cells 10.64 ± 0.22 10.93 ± 0.21 10.75 ± 0.21  0.63 < 0.01 0.77 
Granulocytes 3.75 ± 0.18 3.85 ± 0.18 4.02 ± 0.18  0.56 < 0.01 0.58 
Lymphocytes 6.57 ± 0.24 6.77 ± 0.23 6.20 ± 0.23  0.21 0.04 0.59 
Monocytes 0.32 ± 0.05 0.22 ± 0.05 0.26 ± 0.05  0.35 0.72 0.72 
Granulocyte:lymphocyte 75.27 ± 4.77  84.27 ± 4.71 85.48 ± 4.59  0.25 0.04 0.99 
2 Treatments: Control (n = 38) - cows with vaginal purulent discharge (VPD) that received intrauterine infusions of 20 mL of PBS as 
treatment; LPS150 (n = 40) - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS 
as treatment; LPS300 (n = 41) - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 300 µg of E. coli 
LPS as treatment. 
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CHAPTER 3 
The manuscript 
 
Effects of intra-uterine infusion of Escherichia. coli lipopolysaccharide on uterine 
health, resolution of vaginal purulent discharge and reproductive performance of 
lactating dairy cows 
OVERVIEW 
The objectives of the current experiment were to evaluate the effects of intra-
uterine infusion of cows diagnosed with vaginal purulent discharge (VPD) with 
Escherichia coli lipopolysaccharide (LPS) on intrauterine cell population, uterine health 
and reproductive performance of lactating dairy cows. Jersey cows (n = 3,084) were 
examined for vaginal purulent discharge at 31 ± 3 d postpartum using the Metricheck 
device (Simcro, New Zealand; McDougall et al., 2007). Cows with the retrieved exudate 
containing at least 50% of pus were characterized positive for VPD. At examination, 
2,664 cows were negative for VPD and were used as positive controls. There were 420 
(13.6%) cows with > 50% of pus in the retrieved exudate, and from that, 159 VPD cows 
were selected to be treated in the current study. Selected cows were balanced at 31 ± 3 d 
postpartum for lactation number, body condition score, VPD score (mild, moderate, 
severe), and weekly average milk yield, and were randomly assigned to receive 
intrauterine infusion of 20 mL of phosphate-buffered saline (PBS; control, n = 51), or 20 
mL of PBS containing 150 µg (LPS150, n = 54) or 300 µg (LPS300, n = 54) of 
Escherichia coli LPS (E. coli serotype 026:B6, containing 10,000 endotoxin units per mg 
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of LPS; Sigma-Aldrich, St. Louis, MO, USA). Incidences of dystocia, twin calving, male 
calf, retained fetal membrane and metritis were recorded for individual cows. Cows were 
examined with the Metricheck at 7 and 28 d after treatment to evaluate effect of treatment 
on resolution of vaginal purulent discharge. Uterine cytology was performed before 
treatment and again on d 1, 2 and 7 after treatment to evaluate the effects of treatment on 
intrauterine cell population. Reproductive parameters were recorded up to 200 days 
postpartum. Cows diagnosed with VPD at 31 ± 3 d postpartum had greater incidence of 
dystocia (control = 12.2%, LPS150 = 17.0%, LPS300 = 17.0% and healthy = 3.4%), 
retained placenta (control = 13.7%, LPS150 = 16.7%, LPS300 = 9.3% and healthy = 
1.7%) and metritis (control = 25.5%, LPS150 = 24.1%, LPS300 = 20.4% and healthy = 
4.0%) after calving than healthy cows, but there was no difference in incidence of these 
events among cows with VPD only. Incidences of twining (control = 4.1%, LPS150 = 
3.8%, LPS300 = 3.8% and healthy = 1.9%) and male calf (control = 44.9%, LPS150 = 
49.1%, LPS300 = 43.4% and healthy = 48.0%) were not different between cows with 
VPD and healthy cows. Percentage of cows with VPD at 7 (control = 58.0%, LPS150 = 
55.8%, LPS300 = 67.9%) and 28 d (control = 10.6%, LPS150 = 13.7%, LPS300 = 
11.8%) after treatment were not affected by treatment. No differences in percentage of 
polymorphonuclear cells in uterine cytology were observed on d 0 or thereafter. The 
percentage of cows pregnant 31 ± 3 d after first postpartum artificial insemination (AI) 
was lower for control cows (23.9%) than for LPS150 (42.0%), LPS300 (43.8%) and 
healthy (49.9%) cows, but it was similar between LPS treated and healthy cows. 
Furthermore, likelihood of pregnancy 66 days after first postpartum AI was not different 
 67 
 
among LPS150 (36.0%), LPS300 (35.4%) and healthy cows (46.1%), but control cows 
were less likely (21.7%) to be pregnant at 66 ± 3 days after first AI than healthy cows. 
Moreover, pregnancy 31 ± 3 d after the second postpartum AI was higher for healthy 
cows (45.0%) than control (22.2%) and LPS300 (25.0%), but it was not different between 
healthy and LPS150 (40.6%) cows, or among cows with VPD only. Similarly, likelihood 
of pregnancy at 66 ± 3 days after second postpartum AI was higher for healthy cows 
(40.6%) compared to control (22.2%) and LPS 300 (16.0%) cows, but it was not different 
between healthy and LPS150 cows (38.7%) or among cows with VPD only. Pregnancy 
loss after first and second insemination was not affected by treatment. Thus, according to 
the current experiment, intrauterine treatment of cows with VPD using 150 µg of E. coli 
LPS solution improved reproductive performance, but further research is needed to 
elucidate the mechanism by which LPS treatment improved fertility.       
  
INTRODUCTION 
Profitability of dairy farms is greatly affected by the reproductive performance of 
the herd because it affects milk production, number of replacements produced, and 
voluntary and involuntary culling (Britt, 1985). In the first 2 weeks postpartum, cows are 
at high risk for uterine infections caused primarily by Escherichia coli and Trueperella 
pyogenes (Sheldon et al., 2009), concomitant with Prevotella melaninogenicus, 
Fusobacterium spp., Streptococcus spp., Staphylococcus spp., Pasteurella multocida, 
Clostridium spp., and Bacillus licheniformis (Williams et al., 2005). Insufficient intake of 
energy, protein, vitamins and minerals, and dramatic changes in concentrations of 
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steroidal hormones predispose postpartum lactating dairy cows to immunodeficiency and 
uterine infections (Huzzey et al., 2007; LeBlanc, 2008). Uterine bacterial contamination 
occurs in approximately 80 to 90 % of dairy cows during the first two weeks after 
parturition (Sheldon et al., 2009) and 10 to 20% of them develop endometritis (Potter et 
al., 2010), whereas  approximately 30% develop sub-clinical endometritis (Galvão, 
2012). Cows that have dystocia, twining, retained fetal membranes, stillbirth, abortion, 
metritis, male offspring, and ketosis are at higher risk for endometritis (Galvão, 2012).    
Endometritis, an inflammation of the endometrium, has a negative effect on 
profitability because of consequent infertility, increased culling for reproductive failure, 
reduced milk yield, and treatment cost (Sheldon et al., 2009). Clinical endometritis is 
characterized in cattle as the presence of a purulent (> 50% pus) uterine discharge 
detectable in the vagina after 21 DIM or a mucopurulent discharge (approximately 50% 
pus and 50% mucus) detectable in the vagina after 26 DIM without any systemic 
symptoms (Sheldon et al., 2006).  Currently, there are no products approved in the USA 
for intrauterine treatment of endometritic cows. Intrauterine treatment of endometritic 
cows using 500 mg of cephapirin benzathine in 19 g ointment base (Metricure®, Intervet, 
Boxmeer, The Netherlands) is approved in Canada, Europe and New Zealand (Galvão, 
2012), and has been reported to improve reproductive performance of cows with clinical 
(LeBlanc et al., 2002) and subclinical (Kasimanickam et al., 2005) endometritis. 
However, cost of treatment associated with possible development of microbial resistance 
to antibiotics, makes interesting the idea of development non-antimicrobial treatments 
that effectively improves fertility. Furthermore, intra-uterine antibacterial therapy may 
 69 
 
inhibit phagocytic activity of neutrophil in the uterus (Oxender and Seguin, 1976; 
Massera et al., 1980), which may compromise recovery from uterine infections.  
Lipopolysaccharide, a constituent of the outer membrane of gram-negative 
bacteria cell, plays an important role in pathogen recognition and triggering inflammatory 
response (Mogensen, 2009). In mammals, recognition of LPS occurs trough the toll-like 
receptor (TLR) 4 in association with myeloid differentiation factor 2 (MD-2; Park et al., 
2009). After LPS binds to the complex TLR4-MD-2, TLR4 Toll-interleukin 1 receptor 
(TIR) domain plays a critical role in signal transduction and leads to the activation of 
transcription factors such as nuclear factor-κB and members of the interferon-regulatory 
factor family (O’Neill and Bowie, 2007; Lu et al., 2008). The activation of these two 
factors regulates the transcription of a variety of genes, including cytokines and 
chemokines, that control the innate and adaptive immunity (Li and Verma, 2002; 
Schroder et al., 2004). Further, among several systemic and local reactions stimulated by 
many cytokines and chemokines, these proteins stimulate leukocytes migration to 
inflamed tissues. Interleukin-8 for instance, is an important cytokine that act guiding 
leukocytes to the site of inflammation (Harada et al., 1994). Interleukin-1β and TNFα are 
known to induce expression of many adhesion molecules on endothelial cells (Cronstein 
et al., 1992) that through interaction with adhesion molecules expressed by leukocytes, 
allow them to migrate from the blood vessel to the inflamed tissues (Albelda et al., 1994). 
Moreover, LPS has also the ability to stimulate neutrophils killing ability. Through TLR-
4, LPS stimulates NADPH oxidase activation leading to production of large amounts of 
superoxide (Huang et al., 2009).       
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Intra-uterine infusion of endometritic cows with 100 μg of E. coli LPS resulted in 
elimination of uterine bacterial infection in 75% of treated the cows and increased intra-
uterine total leukocyte count, proportion of PMNL, and proportion of live PMNL in the 
uterus (Singh et al., 2000). Further, 8 of the 12 cows treated with LPS conceived, whereas 
only 1 of the 12 untreated controls conceived (Singh et al., 2000). These are promising 
results, but the small number of cows used, the low milk yield (< 22 lb/d), and 
differences in management systems (India vs. USA) precludes extrapolating these results 
to dairy cows in the USA. 
 Therefore, the hypothesis of the current study was that intra-uterine treatment of 
cows with vaginal purulent discharge (VPD) with E. coli LPS increases number of 
PMNL in the uterus, resolves VPD, improves pregnancy per AI after first and second 
postpartum AI, and improves pregnancy rates up to 200 DIM. The objectives of the 
present study were to evaluate the effects of intra-uterine infusion of cows with VPD with 
E. coli LPS on intrauterine cell population, uterine health, and reproductive performance 
of lactating dairy cows.     
 
MATERIAL AND METHODS 
The University of Minnesota Institutional Animal Care and Use Committee 
reviewed and approved all procedures performed in the study. From December 2010 to 
May 2012, lactating Jersey cows (n = 3,084) from a free-stall dairy located in Nicollet 
(MN) were examined for VPD at 31 ± 3 DIM using the Metricheck device (Simcro, New 
Zealand; McDougall et al., 2007). Cows with the retrieved exudate containing at least 
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50% of pus were characterized positive for VPD. At examination, 2,664 cows were 
determined to be healthy and were used as a positive control. Four hundred and twenty 
(13.6%) cows were positive VPD. These cows were examined by palpation per rectum of 
the uterine contents and 110 cows were determined to have large amounts of fluid 
accumulated in the uterus and therefore were not treated in this experiment. From the 
remaining 310 cows with VPD (10.1%), 267 were assigned to treatments (Moraes and 
Chebel, unpublished data), from which 108 were assigned to have the uterus biopsied. 
Because the objective of the present study was to evaluate the effects of LPS treatment on 
uterine health and reproductive performance, and because cows that have the uterus 
biopsied are expected to have lower fertility, data from the remaining 159 cows with 
VPD were used in this experiment. These cows were balanced for lactation number, body 
condition score, VPD score (mild, moderate, severe), and weekly average milk yield, and 
were randomly assigned to receive intrauterine infusion of 20 mL of PBS (control, n = 
51), or 20 mL of PBS containing 150 µg (LPS150, n = 54) or 300 µg (LPS300, n = 54) 
of E. coli LPS (E. coli serotype 026:B6, containing 10,000 endotoxin units per mg of 
LPS; Sigma-Aldrich, St. Louis, MO, USA). Lipopolysaccharide treatment occurred 24 h 
after diagnosis of VPD and enrollment. The doses of LPS used for treatments were 
defined based on a pilot study that demonstrated that intra-uterine infusions of 100, 150, 
200, 250, and 450 µg of LPS diluted in 20 mL of PBS did not pose a risk to the health of 
cows (Moraes and Chebel, unpublished data). Further, data from uterine cytology 
collected 20 h after treatment demonstrated that the correlation between dose of LPS and 
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PMNL isolated was quadratic with maximum response obtained with doses > 200 µg 
(Moraes and Chebel, unpublished data). 
Vaginal Purulent Discharge Score 
Scores for VPD were given based on visual observation of retrieved exudate, 
which was placed on a black plastic plate to improve visualization. Scores were given 
according to the following classification: mild (retrieved exudate contained 
approximately 50 to 60% of pus); moderate (retrieved exudate contained approximately 
60 to 90% of pus); and severe (retrieved exudate contained approximately 90 to 100% 
pus). 
Postpartum Problems 
 Occurrence of dystocia, twin calving, male calf, retained fetal membrane and 
metritis were recorded for all cows examined for VPD using on farm software 
(DairyComp305, Valley Agricultural Software, Tulare, CA) and were collected for 
individual cows.  
Calving ease score was recorded for all cows’ right after calving. Calving ease 
score was defined as follows: 1 (cow that calved by itself but in the close-up pen rather 
than in the maternity pen); 2 (cow that calved by itself in the maternity pen); 3 (cow that 
was unable to calve by itself and therefore required assistance, e.g. correcting calf 
presentation, position and/or posture); 4 (calving that required fetotomy); and 5 (calving 
that required cesarean section). Cows with calving ease score of 3 to 5 were classified as 
having dystocia.  
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Multiparous and primiparous cows were kept in two different pens from 
parturition to 15 DIM. In these pens, cows were evaluated daily by the herd veterinarian 
and trained farm personnel for common postpartum diseases, including retained fetal 
membrane and metritis. An event for retained fetal membrane was recorded for cows that 
retained their placenta for at least 24 h after calving.  All cows were examined daily from 
4 to 12 DIM, and cows with enlarged uterus containing watery, fetid, reddish-brownish 
uterine discharge were classified as having metritis. Cows diagnosed with metritis 
received a ceftiofur hydrochloride sterile suspension (Excenel RTU EZ; Pfizer Animal 
Health, Madison, NJ) for 4 consecutive days at a dose of 2.2 mg/kg of body weight. 
Cows with abnormal uterine discharge on d 5 after treatment were retreated with the 
same dose of Excenel for additional 3 consecutive days. 
Uterine Health and Resolution of Vaginal Purulent Discharge 
To evaluate the effects of intrauterine infusion with LPS on uterine health, treated 
cows were examined with the Metricheck 7 and 28 d after treatment. Resolution of VPD 
was defined when there was less than 50 % of pus in the retrieved exudate. 
Effect of Treatment on Intrauterine Cell Population 
To determine the effect of treatment on intrauterine cell population, all treated 
cows had uterine cytology performed before treatment and again on d 1, 2 and 7 after 
treatment. Cytology was performed using the cytobrush (Cytobrush Plus®, Cooper 
Surgical, Inc) technique. After sample collection the cytobrush was rolled onto a clean 
microscope glass slide, which was stained with modified Wright-Giemsa stain (Protocol-
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Hema3, Biochemical Sciences, Swedesboro, New Jersey, USA). Slides were evaluated 
twice, and at each examination 100 cells excluding erythrocytes were counted under 400x 
magnification by one examiner who was blinded to treatments and interval between 
sample collection and treatment. 
Reproductive Parameters  
Voluntary waiting period was 50 DIM and cows were inseminated when observed 
in estrus after the end of the voluntary waiting period. Cows were presynchronized with 
three injections of prostaglandin (PG) F2α given 41 ± 3, 55 ± 3 and 69 ± 3 DIM. Cows 
not inseminated in estrus were enrolled in the Ovsynch56 protocol (GnRH, 7 d later 
PGF2α, 56 h later GnRH) 81 ± 3 DIM and were inseminated at fixed time 91 ± 3 DIM. As 
for resynchronization of the estrous cycle of non-pregnant cows, cows enrolled in the 
study from December 2010 to September 2011 received the first GnRH of the Ovsynch56 
protocol at 31 ± 3 d after insemination and if diagnosed not pregnant 38 ± 3 d after AI 
received a PGF2α injection at non-pregnancy diagnosis, GnRH 56 h later, and TAI 16h 
later. Cows enrolled in the study from February 2012 to May 2012 were examined by 
ultrasound (5 MHz, Ibex Lite; E. I. Medical Imaging, Loveland, CO) for pregnancy 
diagnosis 31 ± 3 d after AI and non-pregnant cows were enrolled in one of two 
resynchronization protocols depending on ovarian structures present in the ovaries at the 
time of non-pregnancy diagnosis. Cows that had a corpus luteum > 20 mm in diameter 
received an injection of PGF2α, and if not inseminated in estrus in the following 12 d were 
enrolled in the Ovsynch56. Cows that at non-pregnancy diagnosis did not have a corpus 
luteum > 20 mm in diameter received a GnRH injection at non-pregnant diagnosis and 
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were enrolled in the Ovsynch56 protocol 7 d later. Cows diagnosed pregnant at 31 ± 3 or 
38 ± 3 d after AI were re-examined 66 ± 3 and 184 ± 3 d after AI. Pregnancy and 
pregnancy loss after first and second inseminations and rate at which cows became 
pregnant up to 200 DIM were calculated. 
Production Parameters 
Cows were milked thrice daily and all cows received recombinant bST (500 mg 
of Posilac; Elanco Animal Health, Greenfield, IN) every 10 d starting 57 ± 3 DIM. 
Monthly, milk yield, milk fat and protein content, and somatic cell count were recorded 
for individual cows during the official Dairy Herd Improvement Association test. Data 
regarding milk yield, milk fat and protein content, and somatic cell count were collected 
from calving to 200 d postpartum. Energy corrected milk was calculated for each cow 
using the formula (Orth, 1992): 
ECM (kg) = [(kg milk) x 0.327] + [(kg fat) x 12.95] + [(kg protein) x 7.2]. 
Statistical Analysis 
All statistical analyses were conducted using SAS (SAS Institute Inc., Cary, NC). 
Variable treatment was forced in all models.  
Descriptive statistics for incidence of male calf, twin calving, dystocia, retained 
fetal membranes and metritis were analyzed by logistic regression using LOGISTIC 
procedure, and the proportions of cows experiencing each of these events were 
determined using FREQ procedure. The distribution of parity (primiparous vs. 
multiparous) was analyzed by Fisher’s Exact Test using FREQ procedure.  
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Incidence of VPD 7 and 28 d after treatment was analyzed by logistic regression 
using LOGISTIC procedure. Models included just treatment as independent variable 
because there was no difference in occurrence of all parameters evaluated in the 
descriptive statistics among cows with VPD. Proportion of cows with VPD at each 
examination was computed using FREQ procedure.  
Baseline intrauterine PMNL counts and percentage were analyzed by ANOVA 
using the GLM procedure, and PMNL counts and percentage at d 1, 2 and 7 after 
treatment were analyzed by ANOVA for repeated measures using MIXED procedure. 
Model included treatment, time of sample collection, treatment by time interaction, and 
the baseline values as a covariate. Furthermore, percentage of cows with > 10% of 
PMNC in uterine cytology was analyzed by logistic regression using LOGISTIC 
procedure.  
Milk yield and components data were analyzed by ANOVA for repeated 
measures using MIXED procedure. Variables offered to all models included treatment, 
twins, dystocia, retained fetal membranes, metritis, test number (relative to days 
postpartum sample was collected), interaction of treatment and test number, and group 
(relative to the weekly cohorts of cows examined for VPD). Variable group was included 
in the model for analyses of milk production and reproductive performance as two 
different synchronization protocols were used during the study time. Variable was 
retained if P < 0.2. 
Pregnancy at first and second postpartum AI and pregnancy loss between 31 ± 3 
and 66 ± 3 d following first and second postpartum AI were analyzed by logistic 
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regression using LOGISTIC procedure. Treatment, twin calving, dystocia, retained fetal 
membranes, metritis and group were offered to all models and retained if P < 0.2. The 
rates at which cows became pregnant up to 200 DIM were analyzed by Cox proportional 
hazard ratio using the PHREG procedure. Kaplan-Meyer survival analysis using the 
LIFETEST procedure was used to compare the interval from calving to establishment of 
pregnancy among treatments. 
Statistical significance was defined as P ≤ 0.05 and statistical tendencies as 0.05 < 
P < 0.10. 
 
RESULTS 
Incidence of Twins, Male Calves, and Postpartum Health Disorders and Milk Yield 
 The incidences of twins, male calves, and postpartum health disorders of all cows 
examined for VPD 31 ± 3 d postpartum are depicted in Table 4. Cows diagnosed with 
VPD at 31 ± 3 d postpartum had greater incidence of dystocia (control = 12.2%, LPS150 
= 17.0%, LPS300 = 17.0% and healthy = 3.4%), retained placenta (control = 13.7%, 
LPS150 = 16.7%, LPS300 = 9.3% and healthy = 1.7%) and metritis (control = 25.5%, 
LPS150 = 24.1%, LPS300 = 20.4% and healthy = 4.0%) after calving than healthy cows, 
but there was no difference in incidence of these events among VPD cows only. 
Incidences of twining (control = 4.1%, LPS150 = 3.8%, LPS300 = 3.8% and healthy = 
1.9%) and male calf (control = 44.9%, LPS150 = 49.1%, LPS300 = 43.4% and healthy = 
48.0%) were not different between VPD and healthy cows.  
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 There were no (P = 0.97) differences among treatments regarding percentage of 
first lactation cows enrolled (control = 45.1%, LPS150 = 44.4%, LPS300 = 48.2%, 
healthy = 44.7%).    
Daily milk yield from calving to 200 d postpartum was not (P = 0.22) different 
among treated and healthy cows (Table 4). Similarly, yield of energy corrected milk (P = 
0.27) was not different among treated and healthy cows (Table 4). 
Uterine Health and Resolution of Vaginal Purulent Discharge 
 Counts of PMNL in the uterine cytology slides are presented in Figure 10. 
Although there was no statistical difference (P = 0.13) among treatments on percentage 
of PMNL in uterine cytology at baseline, it tended to be greater in control cows (control 
vs LPS150 P = 0.10; control vs LPS300 P = 0.06; LPS150 vs LPS300 P = 0.83). In 
addition, there were no differences in percentage of PMNL on days 1, 2 and 7 (P = 0.33), 
and there was no interaction between treatment and day of sample collection (P = 0.67).  
  Percentage of cows with > 10% of PMNC in uterine cytology (Table 5) was not 
different among treatments on d 0 (58.2%; P = 0.23), d 1 (88.3%; P = 0.27), d 2 (84.2%; 
P = 0.91) or on d 7 (62.6%; P = 0.12). Moreover, percentage of cows with VPD at 7 (P = 
0.40; control = 58.0%, LPS150 = 55.8%, LPS300 = 67.9%) and 28 d (P = 0.89; control = 
10.6%, LPS150 = 13.7%, LPS300 = 11.8%) after treatment was also not affected by 
treatment (Table 5). 
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Reproductive Parameters 
Treatment affected pregnancy per AI to first postpartum AI (Table 6). The 
percentage of cows that were diagnosed pregnant 31± 3 d after the first postpartum AI 
was lower in for control cows (23.9%) compared to LPS150 (P = 0.03, 42.0%), LPS300 
(P = 0.03, 43.8%) and healthy cows (P < 0.01, 49.9%), but pregnancy at 31± 3 d was 
similar (P > 0.49) among LPS treated cows and healthy cows. Furthermore, likelihood of 
pregnancy 66 days after first postpartum AI was not different among LPS150 (P = 0.26, 
36.0%) or LPS300 (P = 0.17, 35.4%) and healthy cows (46.1%), but control cows were 
less likely (P < 0.01, 21.7%) to be pregnant at 66 ± 3 days after the first postpartum AI 
than healthy cows, and tended to have lower pregnancies than LPS150 (P = 0.08) cows. 
Moreover, there were no differences among treatments  in incidence of pregnancy loss 
from 31 ± 3 to 66 ± 3 d (P = 0.26; control = 8.3%, LPS150 = 17.4%, LPS300 = 18.2%, 
healthy = 7.2%) after the first postpartum AI, but healthy cows tended (P = 0.07) to have 
lower pregnancy loss than LPS300 cows. Pregnancy to second postpartum AI was also 
affected by treatment (Table 6). The percentage of cows diagnosed pregnant 31 ± 3 d 
after the second postpartum AI was higher for healthy cows (45.0%) than control (P = 
0.02, 22.2%) and LPS300 (P = 0.05, 25.0%), but there was no difference in pregnancy 31 
± 3 d after the second postpartum AI  between healthy and LPS150 cows (P = 0.47 ; 
40.6%) or among VPD cows only (P > 0.19). Similarly, likelihood of pregnancy at 66 ± 3 
days after second postpartum AI was higher in healthy cows (40.6%) compared to control 
(P = 0.05, 22.2%) and LPS 300 (P = 0.02, 16.0%) cows, but pregnancy at 66 ± 3 days 
was not different between healthy and LPS150 cows (P = 0.67, 38.7%) or among VPD 
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cows only (P > 0.11) (Table 6). Pregnancy loss from 31 ± 3 to 66 ± 3 d after the second 
postpartum AI was not affected by treatment (P = 1.00). Due to small sample size for 
treated cows (control, n = 8; LPS150, n = 12; LPS300, n = 4), evaluation of  pregnancy 
loss after second postpartum AI was compromised, being 0% for all VPD cows, and 
therefore the calculation of the adjusted odds ratio was not possible. Pregnancy loss after 
second postpartum AI was 6.4% (544/1,253) for healthy cows.   
 Treatment affected (P < 0.01) the rate at which cows became pregnant up to 200 d 
postpartum (Table 6). Pregnancy rate of healthy cows was greater than that of control (P 
< 0.01) and LPS300 (P = 0.05) cows, but pregnancy rates of healthy and LPS150 cows 
were not (P = 0.16) different (P = 0.16). The median and mean intervals from calving to 
conception were different among treatments (control = 129 and 123.5 d; LPS150 = 92.5 
and 106.1 d; LPS300 = 116 and 111.6 d; healthy = 83 and 100 d; Figure 11). 
 
DISCUSSION 
We demonstrated that treatment of cows with VPD at 31 ± 3 DIM with 
intrauterine infusion of 20 mL of PBS containing 150 μg of E. coli LPS improved 
reproductive performance when compared with cows with VPD that received intrauterine 
infusion with PBS. Pregnancy at first postpartum AI was not different among LPS150, 
LPS300, and healthy cows, but control cows were less likely to be pregnant after first 
postpartum AI than healthy cows. Moreover, pregnancy at second postpartum AI and 
pregnancy rate up to 200 DIM was not different between LPS150 and healthy cows. The 
improvement in pregnancy to first postpartum AI resulting from the LPS intra-uterine is 
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very significant particularly because cows diagnosed with VPD were also more likely to 
have peripartum diseases such as dystocia, retained fetal membranes, and metritis that are 
known to reduce pregnancy per AI. Retained placenta and metritis for instance, are 
reported to reduce conception rate and to extend intervals to pregnancy (Goshen and 
Shpiegel, 2006), and dystocia has been reported to increase number of services and days 
open (Dematawewa and Berger, 1997).     
The improvement in reproductive performance of cows with VPD treated with 
intra-uterine infusion with LPS observed in the present study is in accordance with 
findings reported by Singh et al. (2000). It is worth noting that Singh et al. (2000) treated 
endometritic cows on the day they were observed in estrus expression, whereas in the 
current experiment cows were treated independently of phase of estrus cycle. Treating 
endometritic cows on the day of estrous expression could potentiate LPS 
immunomodulatory action because cows have lower progesterone concentrations during 
estrus, reducing the immunosuppressant effects of progesterone (Siiteri et al., 1977; 
Hansen, 2013). On the other hand, treatment of endometritic cows expressing estrus or on 
the day of AI would be difficult to implement in a commercial dairy farm. Secondly, the 
treatment would be limited to the cows that exhibit estrus signs, and estrus expression in 
endometritic cows is compromised as postpartum uterine infection negatively affects 
ovarian function (Sheldon et al., 2002; Williams et al., 2007; Williams et al., 2008; 
Sheldon et al., 2009).  
Lipopolysaccharide did not cause systemic sickness in treated cows. Williams et 
al. (2008) infused 3 µg/kg of LPS in the uterus of Holstein heifers and observed no 
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detrimental effect on rectal temperature or concentration of alpha-1acid glycoprotein. 
However, fewer heifers treated with LPS ovulated compared with heifers treated with 
PBS and, among heifers that ovulated, progesterone concentration was lower in heifers 
treated with LPS compared with those treated with PBS.    
Despite improvements in reproductive performance observed in LPS treated 
cows, no differences among treatments in resolution of VPD 7 and 28 d after treatment 
were observed. Moreover, there were no differences among treatments in incidence of 
subclinical endometritis 7 d after treatment. Therefore, we speculated that there was an 
improvement in uterine health posterior to the first week after treatment, but the 
metricheck technique performed on d 28 may not have been sensitive enough to detect 
improvements in uterine condition in LPS treated cows.  The number of PMNL in the 
uterine cytology increased in approximately 60% in LPS treated cows within 24 h after 
treatment and then returned to pre-treatment counts by 7 d after treatment. On the other 
hand, number of PMNL in uterine cytology of control cows remained relatively constant 
from pre-treatment to 7 d after treatment. More experiments are necessary to determine if 
the fast influx of PMNL into the uterus resulting from LPS infusion resolves mild uterine 
infections and improves uterine health beyond 7 d after treatment. Even though the 
mechanism by which LPS improved fertility is not completely clear, LPS treatment 
increased percentage of PMNL positive for phagocytosis and oxidative burst, and 
increased intensity of expression of CD18 by PMNL (Moraes et al., 2013). The CD18 
adhesion molecule is a member of the β2-integrins subfamily and plays important role in 
the PMNL firm adhesion to and diapedesis through endothelium during inflammation 
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(Carlos and Harlan, 1994). Thus, increased CD18 expression in PMNL of LPS treated 
cows may explain the greater number of PMNL in uterine cytology of LPS treated cows 
24 h after intra-uterine infusion. This increased PMNL expression of CD18, phagocytosis 
and oxidative burst, may be caused by LPS intra-uterine infusion and production of pro-
inflammatory cytokines and chemokine (TNFα, IL-1, IL-6, IL-8; Wright, 1999). 
Endometrial mRNA expressions of adhesion molecules (E-selectin, ICAM-1 and VCAM-
1), inflammatory cytokines (IL-1β, IL-6, IL-8 and IL-10) and TLR-4 at 6 and 24 h after 
treatment were not different among LPS150, LPS300, and control cows (Moraes et al., 
2013a). It is possible that the timing of endometrial biopsy was not ideal to demonstrate 
effects of LPS treatment on regulation of mRNA expression of such molecules, since 
peak mammary mRNA expression of TNF-α after LPS intra-mammary infusion occurred 
at 3 h after treatment and values were back to baseline values by 12 h after treatment 
(Schmitz et al., 2004).  
 
CONCLUSIONS 
Treatment of VPD cows with intrauterine infusion of 150 µg of E. coli LPS 
improved reproductive performance compared with VPD cows that treated with PBS or 
300 µg of E. coli LPS intrauterine infusion. It is possible that the high influx of PMNL 
resulting from LPS intrauterine treatment resulted in clearing of intrauterine infections 
and improvement of uterine health. The lack of differences in cure from VPD may be 
because of the poor accuracy of Metricheck to determine intrauterine health. More 
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experiments are needed to elucidate more clearly the mechanisms through which 
intrauterine LPS treatment improves pregnancy per AI of cows with VPD. 
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Figure 10. Effect of LPS intrauterine treatment on count of PMNL from endometrial 
cytology. Treatments: Control - cows with vaginal purulent discharge (VPD) that 
received intrauterine infusions of 20 mL of PBS as treatment; LPS150 - cows with VPD 
that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS as 
treatment; LPS300 - cows with VPD that received intrauterine infusions of 20 mL of PBS 
containing 300 µg of E. coli LPS as treatment. ** PMNL count tended to be greater in 
control cows than LPS150 (P = 0.10) and LPS300 (P = 0.06) cows. There were no 
differences in counts of PMNL on days 1, 2 and 7 (P = 0.33), and there was no 
interaction between treatment and day of sample collection (P = 0.67). 
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Figure 11. Effect of LPS intrauterine treatment on survival distribution of time to 
pregnancy up to 200 days postpartum. Effect of treatment according to the Wilcoxon test 
of equality: P < 0.01. Treatments: Control - cows with vaginal purulent discharge (VPD) 
that received intrauterine infusions of 20 mL of PBS as treatment; LPS150 - cows with 
VPD that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli 
LPS as treatment; LPS300 - cows with VPD that received intrauterine infusions of 20 mL 
of PBS containing 300 µg of E. coli LPS as treatment; Healthy - composed by healthy 
cows at Metricheck examination (less than 50% of pus in retrieved exudate). Pregnancy 
rate of healthy cows was greater than that of control [P < 0.01; AHR (95% CI) = 0.59 
(0.41, 0.84)] and LPS300 [P = 0.05; AHR (95% CI) = 0.71 (0.50, 0.99)] cows, but 
pregnancy rate of healthy and LPS150 cows was not different [P = 0.16; AHR (95 % CI) 
= 0.79 (0.57, 1.10)].
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Table 4. Incidence of postpartum problems among cows diagnosed with vaginal purulent discharge and health cows. 
Items 
Treatments 
P - value 
Control2 LPS1502 LPS3002 Healthy2 
Percentage of first lactation cows, % 45.1 44.4 48.2 44.7 0.97 
Twins, AOR (95 % CI)1 
2.24 
(0.53, 9.49) 
2.01 
(0.49, 8.73) 
2.01 
(0.49, 8.73) 
Ref. 0.40 
Male calf, AOR (95 % CI)1 
0.88  
(0.50, 1.56) 
1.04 
(0.61, 1.80) 
0.83 
(0.48, 1.44) 
Ref. 0.89 
Dystocia, AOR (95 % CI)1 
3.94 
(1.63, 9.49) 
5.77 
(2.73, 12.19) 
5.77 
(2.73, 12.19) 
Ref. < 0.01 
Retained fetal membranes,  
AOR (95 % CI)1 
9.26  
(3.96, 21.67) 
11.64 
(5.37, 25.24) 
5.939 
(2.26, 15.61) 
Ref. < 0.01 
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Metritis, AOR (95 % CI)1 
8.17 
(4.23, 15.80) 
7.58 
(3.94, 14.56) 
6.11 
(3.07, 12.19) 
Ref. < 0.01 
Milk yield, kg/d 
30.02 ± 1.09 32.05 ± 1.05 31.34 ± 1.07 30.12 ± 0.16 0.22 
Yield of energy corrected milk, kg/d
34.34 ± 1.14 36.60 ± 1.10 35.83 ± 1.11 34.70 ± 0.17 0.27 
1 AOR = Adjusted odds ratio; 95% CI = 95% confidence interval 
2 Treatments: Control - cows with vaginal purulent discharge (VPD) that received intrauterine infusions of 20 mL of PBS as 
treatment; LPS150 - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS as 
treatment; LPS300 - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 300 µg of E. coli LPS as 
treatment; Healthy - composed by healthy cows at Metricheck examination (less than 50% of pus in retrieved exudate). 
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Table 5. Intrauterine cell population and resolution of vaginal purulent discharge following treatment. 
 Treatment P – value 
 Control1 LPS1501 LPS3001 
Cows with > 10% of PMNL in uterine cytology, % (n)     
d 0 before treatment 66.7 (51) 58.5 (53) 50.0 (54) 0.23 
d 1 after treatment 84.0 (50) 94.2 (52) 86.5 (52) 0.27 
d 2 after treatment 82.4 (51) 84.9 (53) 85.2 (54) 0.91 
d 7 after treatment 72.3 (47) 64.0 (50) 52.0 (50) 0.12 
Cows with VPD 7 d after treatment, AOR (95 % CI)1 Ref. 0.91 (0.42, 2.00) 1.53 (0.69, 3.43) 0.40 
Cows with VPD 28 d after treatment, AOR (95 % CI)1 Ref. 1.34 (0.39, 4.54) 1.12 (0.32, 3.95)   0.89 
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1 AOR = Adjusted odds ratio; 95% CI = 95% confidence interval 
2 Treatments: Control - cows with vaginal purulent discharge (VPD) that received intrauterine infusions of 20 mL of PBS as treatment; 
LPS150 - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS as treatment; LPS300 - 
cows with VPD that received intrauterine infusions of 20 mL of PBS containing 300 µg of E. coli LPS as treatment. 
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Table 6. Effects of LPS treatment on percentage of cows pregnant after first and second postpartum AI, pregnancy loss for first 
and second AI and rate at which cows became pregnant up to 200 d postpartum. 
 Treatment P – 
value  Control3 LPS1503 LPS3003 Healthy3 
First postpartum AI, AOR (95 % CI)1      
P/AI 31 ± 3 d after AI 
  
0.30 (0.15, 0.61)a  0.81 (0.45, 1.46)b 0.81 (0.45, 1.46)b  Ref.b  < 0.01 
P/AI 66 ± 3 d after AI 
  
0.30 (0.14, 0.64)a,A 0.71 (0.39, 1.29)B 0.66 (0.36, 1.20) Ref.b  < 0.01 
Pregnancy loss  
from 31 ± 3 to 66 ± 3 d after AI 
  
1.09 (0.13, 9.38) 1.97 (0.54, 7.22) 2.86 (0.91, 8.99) A Ref.B  0.26 
Second postpartum AI, AOR (95 % CI)1      
P/AI 31 ± 3 d after AI 0.37 (0.17, 0.83)a  0.76 (0.36, 1.60) 0.41 (0.17, 0.99)a  Ref.b  0.02 
P/AI 66 ± 3 d after AI 0.45 (0.20, 1.00)a  0.85 (0.40,  1.82) 0.29 (0.10, 0.85)a  Ref.b  0.03 
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Pregnancy rate up to 200 d, AHR(95% CI)2 0.59 (0.41, 0.84)a 0.79 (0.57, 1.10) 0.71 (0.50, 0.99)a Ref.b < 0.01 
a,b Within a row, numbers with lowercase letters (a,b) are different (P < 0.05) 
A,B Within a row, numbers with uppercase letters (A,B) tended (0.05 < P < 0.10) to be different.  
1 AOR = Adjusted odds ratio; 95% CI = 95% confidence interval 
2 AHR = Adjusted hazard ratio; 95% CI = 95% confidence interval 
3 Treatments: Control - cows with vaginal purulent discharge (VPD) that received intrauterine infusions of 20 mL of PBS as 
treatment; LPS150 - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 150 µg of E. coli LPS as 
treatment; LPS300 - cows with VPD that received intrauterine infusions of 20 mL of PBS containing 300 µg of E. coli LPS as 
treatment; Healthy - composed by healthy cows at Metricheck examination (less than 50% of pus in retrieved exudate). 
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